<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2014-10-29" version="221">
<accession>P10275</accession>
<accession>A2RUN2</accession>
<accession>B1AKD7</accession>
<accession>Q9UD95</accession>
<name>ANDR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Androgen receptor</fullName>
</recommendedName>
<alternativeName>
<fullName>Dihydrotestosterone receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor subfamily 3 group C member 4</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AR</name>
<name type="synonym">DHTR</name>
<name type="synonym">NR3C4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Mol. Endocrinol." volume="2" first="1265" last="1275">
<title>The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate.</title>
<authorList>
<person name="Lubahn D.B."/>
<person name="Joseph D.R."/>
<person name="Sar M."/>
<person name="Tan J."/>
<person name="Higgs H.N."/>
<person name="Larson R.E."/>
<person name="French F.S."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="3216866"/>
<dbReference type="DOI" id="10.1210/mend-2-12-1265"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="7211" last="7215">
<title>Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors.</title>
<authorList>
<person name="Chang C."/>
<person name="Kokontis J."/>
<person name="Liao S."/>
</authorList>
<dbReference type="PubMed" id="3174628"/>
<dbReference type="DOI" id="10.1073/pnas.85.19.7211"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="327" last="331">
<title>Characterization and expression of a cDNA encoding the human androgen receptor.</title>
<authorList>
<person name="Tilley W.D."/>
<person name="Marcelli M."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="2911578"/>
<dbReference type="DOI" id="10.1073/pnas.86.1.327"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="9534" last="9538">
<title>Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity.</title>
<authorList>
<person name="Lubahn D.B."/>
<person name="Brown T.R."/>
<person name="Simental J.A."/>
<person name="Higgs H.N."/>
<person name="Migeon C.J."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="2594783"/>
<dbReference type="DOI" id="10.1073/pnas.86.23.9534"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT AIS MET-866</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="417" last="427">
<title>Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.</title>
<authorList>
<person name="Govindan M.V."/>
</authorList>
<dbReference type="PubMed" id="2342476"/>
<dbReference type="DOI" id="10.1210/mend-4-3-417"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT DEL GLY-465--472-GLY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="1105" last="1116">
<title>Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Tilley W.D."/>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="2293020"/>
<dbReference type="DOI" id="10.1210/mend-4-8-1105"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="FEBS J." volume="272" first="74" last="84">
<title>Androgen receptor function is modulated by the tissue-specific AR45 variant.</title>
<authorList>
<person name="Ahrens-Fath I."/>
<person name="Politz O."/>
<person name="Geserick C."/>
<person name="Haendler B."/>
</authorList>
<dbReference type="PubMed" id="15634333"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.2004.04395.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>POLYMORPHISM OF POLY-GLY REGION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1989" name="Mol. Cell. Endocrinol." volume="61" first="257" last="262">
<title>The N-terminal domain of the human androgen receptor is encoded by one, large exon.</title>
<authorList>
<person name="Faber P.W."/>
<person name="Kuiper G.G.J.M."/>
<person name="van Rooij H.C.J."/>
<person name="van der Korput J.A.G.M."/>
<person name="Brinkmann A.O."/>
<person name="Trapman J."/>
</authorList>
<dbReference type="PubMed" id="2917688"/>
<dbReference type="DOI" id="10.1016/0303-7207(89)90137-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-538</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1988" name="Science" volume="240" first="324" last="326">
<title>Molecular cloning of human and rat complementary DNA encoding androgen receptors.</title>
<authorList>
<person name="Chang C."/>
<person name="Kokontis J."/>
<person name="Liao S."/>
</authorList>
<dbReference type="PubMed" id="3353726"/>
<dbReference type="DOI" id="10.1126/science.3353726"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 189-919 (ISOFORM 1)</scope>
</reference>
<reference key="13">
<citation type="submission" date="1995-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Lu J."/>
<person name="Danielsen M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 446-475</scope>
<scope>POLYMORPHISM OF POLY-GLY REGION</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1988" name="Biochem. Biophys. Res. Commun." volume="153" first="241" last="248">
<title>Cloning, structure and expression of a cDNA encoding the human androgen receptor.</title>
<authorList>
<person name="Trapman J."/>
<person name="Klaassen P."/>
<person name="Kuiper G.G.J.M."/>
<person name="van der Korput J.A.G.M."/>
<person name="Faber P.W."/>
<person name="van Rooij H.C.J."/>
<person name="Geurts van Kessel A."/>
<person name="Voorhorst M.M."/>
<person name="Mulder E."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="3377788"/>
<dbReference type="DOI" id="10.1016/S0006-291X(88)81214-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 468-919 (ISOFORM 1)</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1989" name="J. Mol. Endocrinol." volume="2" first="R1" last="R4">
<title>Structural organization of the human androgen receptor gene.</title>
<authorList>
<person name="Kuiper G.G."/>
<person name="Faber P.W."/>
<person name="van Rooij H.C."/>
<person name="van der Korput J.A."/>
<person name="Ris-Stalpers C."/>
<person name="Klaassen P."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="2546571"/>
<dbReference type="DOI" id="10.1677/jme.0.002R001"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 536-540; 587-591; 626-630; 722-726; 770-774; 814-817 AND 866-870</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="861" last="869">
<title>A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.</title>
<authorList>
<person name="Mowszowicz I."/>
<person name="Lee H.-J."/>
<person name="Chen H.-T."/>
<person name="Mestayer C."/>
<person name="Portois M.-C."/>
<person name="Cabrol S."/>
<person name="Mauvais-Jarvis P."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="8413310"/>
<dbReference type="DOI" id="10.1210/mend.7.7.8413310"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 557-624 (ISOFORMS 1/2)</scope>
<scope>VARIANT AIS HIS-615</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="1988" name="Science" volume="240" first="327" last="330">
<title>Cloning of human androgen receptor complementary DNA and localization to the X chromosome.</title>
<authorList>
<person name="Lubahn D.B."/>
<person name="Joseph D.R."/>
<person name="Sullivan P.M."/>
<person name="Willard H.F."/>
<person name="French F.S."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="3353727"/>
<dbReference type="DOI" id="10.1126/science.3353727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 559-624 (ISOFORMS 1/2)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1991" name="Mol. Endocrinol." volume="5" first="1562" last="1569">
<title>Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics.</title>
<authorList>
<person name="Ris-Stalpers C."/>
<person name="Trifiro M.A."/>
<person name="Kuiper G.G.J.M."/>
<person name="Jenster G."/>
<person name="Romalo G."/>
<person name="Sai T."/>
<person name="van Rooij H.C.J."/>
<person name="Kaufman M."/>
<person name="Rosenfield R.L."/>
<person name="Liao S."/>
<person name="Schweikert H.-U."/>
<person name="Trapman J."/>
<person name="Pinsky L."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="1775137"/>
<dbReference type="DOI" id="10.1210/mend-5-10-1562"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 629-723</scope>
<scope>VARIANTS AIS ASN-695 AND HIS-695</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1992" name="Nucleic Acids Res." volume="20" first="1427" last="1427">
<title>Trinucleotide repeat polymorphism in the androgen receptor gene (AR).</title>
<authorList>
<person name="Sleddens H.F.B.M."/>
<person name="Oostra B.A."/>
<person name="Brinkmann A.O."/>
<person name="Trapman J."/>
</authorList>
<dbReference type="PubMed" id="1561105"/>
<dbReference type="DOI" id="10.1093/nar/20.6.1427-a"/>
</citation>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="3320" last="3323">
<title>The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.</title>
<authorList>
<person name="Giovannucci E."/>
<person name="Stampfer M.J."/>
<person name="Krithivas K."/>
<person name="Brown M."/>
<person name="Dahl D."/>
<person name="Brufsky A."/>
<person name="Talcott J."/>
<person name="Hennekens C.H."/>
<person name="Kantoff P.W."/>
</authorList>
<dbReference type="PubMed" id="9096391"/>
<dbReference type="DOI" id="10.1073/pnas.94.7.3320"/>
</citation>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="8272" last="8272">
<authorList>
<person name="Giovannucci E."/>
<person name="Stampfer M.J."/>
<person name="Krithivas K."/>
<person name="Brown M."/>
<person name="Dahl D."/>
<person name="Brufsky A."/>
<person name="Talcott J."/>
<person name="Hennekens C.H."/>
<person name="Kantoff P.W."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="977" last="987">
<title>PQBP-1, a novel polyglutamine tract binding protein, inhibits transcription activation by Brn-2 and affects cell survival.</title>
<authorList>
<person name="Waragai M."/>
<person name="Lammers C.-H."/>
<person name="Takeuchi S."/>
<person name="Imafuku I."/>
<person name="Udagawa Y."/>
<person name="Kanazawa I."/>
<person name="Kawabata M."/>
<person name="Mouradian M.M."/>
<person name="Okazawa H."/>
</authorList>
<dbReference type="PubMed" id="10332029"/>
<dbReference type="DOI" id="10.1093/hmg/8.6.977"/>
</citation>
<scope>INTERACTION WITH PQBP1</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8316" last="8321">
<title>Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate.</title>
<authorList>
<person name="Fujimoto N."/>
<person name="Yeh S."/>
<person name="Kang H.-Y."/>
<person name="Inui S."/>
<person name="Chang H.-C."/>
<person name="Mizokami A."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="10075738"/>
<dbReference type="DOI" id="10.1074/jbc.274.12.8316"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="19441" last="19446">
<title>Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.</title>
<authorList>
<person name="Poukka H."/>
<person name="Aarnisalo P."/>
<person name="Karvonen U."/>
<person name="Palvimo J.J."/>
<person name="Jaenne O.A."/>
</authorList>
<dbReference type="PubMed" id="10383460"/>
<dbReference type="DOI" id="10.1074/jbc.274.27.19441"/>
</citation>
<scope>INTERACTION WITH UBE2I</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="20229" last="20234">
<title>The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator.</title>
<authorList>
<person name="Hsiao P.-W."/>
<person name="Lin D.-L."/>
<person name="Nakao R."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="10400640"/>
<dbReference type="DOI" id="10.1074/jbc.274.29.20229"/>
</citation>
<scope>INTERACTION WITH RAN</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="1216" last="1225">
<title>PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression.</title>
<authorList>
<person name="Oettgen P."/>
<person name="Finger E."/>
<person name="Sun Z."/>
<person name="Akbarali Y."/>
<person name="Thamrongsak U."/>
<person name="Boltax J."/>
<person name="Grall F."/>
<person name="Dube A."/>
<person name="Weiss A."/>
<person name="Brown L."/>
<person name="Quinn G."/>
<person name="Kas K."/>
<person name="Endress G."/>
<person name="Kunsch C."/>
<person name="Libermann T.A."/>
</authorList>
<dbReference type="PubMed" id="10625666"/>
<dbReference type="DOI" id="10.1074/jbc.275.2.1216"/>
</citation>
<scope>INTERACTION WITH SPDEF</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="35200" last="35208">
<title>Androgen receptor interacts with a novel MYST protein, HBO1.</title>
<authorList>
<person name="Sharma M."/>
<person name="Zarnegar M."/>
<person name="Li X."/>
<person name="Lim B."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="10930412"/>
<dbReference type="DOI" id="10.1074/jbc.M004838200"/>
</citation>
<scope>INTERACTION WITH KAT7</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="14145" last="14150">
<title>Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).</title>
<authorList>
<person name="Poukka H."/>
<person name="Karvonen U."/>
<person name="Jaenne O.A."/>
<person name="Palvimo J.J."/>
</authorList>
<dbReference type="PubMed" id="11121022"/>
<dbReference type="DOI" id="10.1073/pnas.97.26.14145"/>
</citation>
<scope>SUMOYLATION AT LYS-386 AND LYS-520</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="48020" last="48027">
<title>RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor.</title>
<authorList>
<person name="Rao M.A."/>
<person name="Cheng H."/>
<person name="Quayle A.N."/>
<person name="Nishitani H."/>
<person name="Nelson C.C."/>
<person name="Rennie P.S."/>
</authorList>
<dbReference type="PubMed" id="12361945"/>
<dbReference type="DOI" id="10.1074/jbc.M209741200"/>
</citation>
<scope>INTERACTION WITH RANBP9</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="30031" last="30039">
<title>Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Goto K."/>
<person name="Saitoh M."/>
<person name="Yanase T."/>
<person name="Nomura M."/>
<person name="Okabe T."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="12039962"/>
<dbReference type="DOI" id="10.1074/jbc.M203811200"/>
</citation>
<scope>INTERACTION WITH PRPF6</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14783" last="14788">
<title>Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.</title>
<authorList>
<person name="Wong C.-W."/>
<person name="McNally C."/>
<person name="Nickbarg E."/>
<person name="Komm B.S."/>
<person name="Cheskis B.J."/>
</authorList>
<dbReference type="PubMed" id="12415108"/>
<dbReference type="DOI" id="10.1073/pnas.192569699"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="6101" last="6114">
<title>hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci.</title>
<authorList>
<person name="Sharma M."/>
<person name="Li X."/>
<person name="Wang Y."/>
<person name="Zarnegar M."/>
<person name="Huang C.-Y."/>
<person name="Palvimo J.J."/>
<person name="Lim B."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="14609956"/>
<dbReference type="DOI" id="10.1093/emboj/cdg585"/>
</citation>
<scope>INTERACTION WITH ZMIZ1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="46087" last="46093">
<title>The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway.</title>
<authorList>
<person name="Rigas A.C."/>
<person name="Ozanne D.M."/>
<person name="Neal D.E."/>
<person name="Robson C.N."/>
</authorList>
<dbReference type="PubMed" id="12958311"/>
<dbReference type="DOI" id="10.1074/jbc.M306219200"/>
</citation>
<scope>INTERACTION WITH GNB2L1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2003" name="J. Mol. Endocrinol." volume="31" first="583" last="596">
<title>The retinoblastoma protein-associated transcription repressor RBaK interacts with the androgen receptor and enhances its transcriptional activity.</title>
<authorList>
<person name="Hofman K."/>
<person name="Swinnen J.V."/>
<person name="Claessens F."/>
<person name="Verhoeven G."/>
<person name="Heyns W."/>
</authorList>
<dbReference type="PubMed" id="14664718"/>
<dbReference type="DOI" id="10.1677/jme.0.0310583"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RBAK</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="247" last="261">
<title>DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex.</title>
<authorList>
<person name="Niki T."/>
<person name="Takahashi-Niki K."/>
<person name="Taira T."/>
<person name="Iguchi-Ariga S.M.M."/>
<person name="Ariga H."/>
</authorList>
<dbReference type="PubMed" id="12612053"/>
</citation>
<scope>INTERACTION WITH EFCAB6</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="1922" last="1931">
<title>Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling.</title>
<authorList>
<person name="Schrantz N."/>
<person name="da Silva Correia J."/>
<person name="Fowler B."/>
<person name="Ge Q."/>
<person name="Sun Z."/>
<person name="Bokoch G.M."/>
</authorList>
<dbReference type="PubMed" id="14573606"/>
<dbReference type="DOI" id="10.1074/jbc.M311145200"/>
</citation>
<scope>PHOSPHORYLATION BY PAK6</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="170" first="191" last="200">
<title>Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors.</title>
<authorList>
<person name="Mills I.G."/>
<person name="Gaughan L."/>
<person name="Robson C."/>
<person name="Ross T."/>
<person name="McCracken S."/>
<person name="Kelly J."/>
<person name="Neal D.E."/>
</authorList>
<dbReference type="PubMed" id="16027218"/>
<dbReference type="DOI" id="10.1083/jcb.200503106"/>
</citation>
<scope>INTERACTION WITH HIP1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2005" name="Mol. Endocrinol." volume="19" first="2915" last="2929">
<title>hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes.</title>
<authorList>
<person name="Huang C.-Y."/>
<person name="Beliakoff J."/>
<person name="Li X."/>
<person name="Lee J."/>
<person name="Li X."/>
<person name="Sharma M."/>
<person name="Lim B."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="16051670"/>
<dbReference type="DOI" id="10.1210/me.2005-0097"/>
</citation>
<scope>INTERACTION WITH ZMIZ2</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="Cancer Cell" volume="10" first="309" last="319">
<title>Regulation of androgen receptor activity by tyrosine phosphorylation.</title>
<authorList>
<person name="Guo Z."/>
<person name="Dai B."/>
<person name="Jiang T."/>
<person name="Xu K."/>
<person name="Xie Y."/>
<person name="Kim O."/>
<person name="Nesheiwat I."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Handratta V.D."/>
<person name="Njar V.C."/>
<person name="Brodie A.M."/>
<person name="Yu L.-R."/>
<person name="Veenstra T.D."/>
<person name="Chen H."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="17045208"/>
<dbReference type="DOI" id="10.1016/j.ccr.2006.08.021"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-223; TYR-267; TYR-307; TYR-346; TYR-357; TYR-362; TYR-363; TYR-393; TYR-534; TYR-551 AND TYR-915</scope>
<scope>MUTAGENESIS OF TYR-223; TYR-267; TYR-307; TYR-346; TYR-357; TYR-362; TYR-363; TYR-393; TYR-534; TYR-551 AND TYR-915</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="Cancer Cell" volume="11" first="97" last="97">
<authorList>
<person name="Guo Z."/>
<person name="Dai B."/>
<person name="Jiang T."/>
<person name="Xu K."/>
<person name="Xie Y."/>
<person name="Kim O."/>
<person name="Nesheiwat I."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Handratta V.D."/>
<person name="Njar V.C."/>
<person name="Brodie A.M."/>
<person name="Yu L.-R."/>
<person name="Veenstra T.D."/>
<person name="Chen H."/>
<person name="Qiu Y."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="8439" last="8447">
<title>Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.</title>
<authorList>
<person name="Ma A.H."/>
<person name="Xia L."/>
<person name="Desai S.J."/>
<person name="Boucher D.L."/>
<person name="Guan Y."/>
<person name="Shih H.M."/>
<person name="Shi X.B."/>
<person name="deVere White R.W."/>
<person name="Chen H.W."/>
<person name="Tepper C.G."/>
<person name="Kung H.J."/>
</authorList>
<dbReference type="PubMed" id="16951154"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-1636"/>
</citation>
<scope>INTERACTION WITH MAK</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="J. Steroid Biochem. Mol. Biol." volume="107" first="1" last="14">
<title>PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor.</title>
<authorList>
<person name="Meyer R."/>
<person name="Wolf S.S."/>
<person name="Obendorf M."/>
</authorList>
<dbReference type="PubMed" id="17587566"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2007.05.006"/>
</citation>
<scope>INTERACTION WITH PRMT2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="Mol. Endocrinol." volume="21" first="2056" last="2070">
<title>The zinc finger protein Ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer.</title>
<authorList>
<person name="Mukhopadhyay N.K."/>
<person name="Cinar B."/>
<person name="Mukhopadhyay L."/>
<person name="Lutchman M."/>
<person name="Ferdinand A.S."/>
<person name="Kim J."/>
<person name="Chung L.W.K."/>
<person name="Adam R.M."/>
<person name="Ray S.K."/>
<person name="Leiter A.B."/>
<person name="Richie J.P."/>
<person name="Liu B.C.-S."/>
<person name="Freeman M.R."/>
</authorList>
<dbReference type="PubMed" id="17550981"/>
<dbReference type="DOI" id="10.1210/me.2006-0503"/>
</citation>
<scope>INTERACTION WITH RREB1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="368" first="121" last="125">
<title>RanBP10 acts as a novel coactivator for the androgen receptor.</title>
<authorList>
<person name="Harada N."/>
<person name="Yokoyama T."/>
<person name="Yamaji R."/>
<person name="Nakano Y."/>
<person name="Inui H."/>
</authorList>
<dbReference type="PubMed" id="18222118"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.01.072"/>
</citation>
<scope>INTERACTION WITH RANBP10</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="8438" last="8443">
<title>Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.</title>
<authorList>
<person name="Mahajan N.P."/>
<person name="Liu Y."/>
<person name="Majumder S."/>
<person name="Warren M.R."/>
<person name="Parker C.E."/>
<person name="Mohler J.L."/>
<person name="Earp H.S."/>
<person name="Whang Y.E."/>
</authorList>
<dbReference type="PubMed" id="17494760"/>
<dbReference type="DOI" id="10.1073/pnas.0700420104"/>
</citation>
<scope>INTERACTION WITH TNK2</scope>
<scope>PHOSPHORYLATION AT TYR-267 AND TYR-363 BY TNK2</scope>
<scope>MUTAGENESIS OF TYR-267 AND TYR-363</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="3486" last="3494">
<title>TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.</title>
<authorList>
<person name="Miyajima N."/>
<person name="Maruyama S."/>
<person name="Bohgaki M."/>
<person name="Kano S."/>
<person name="Shigemura M."/>
<person name="Shinohara N."/>
<person name="Nonomura K."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="18451177"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-6059"/>
</citation>
<scope>INTERACTION WITH TRIM68</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Mol. Endocrinol." volume="22" first="1606" last="1621">
<title>Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.</title>
<authorList>
<person name="Kaulfuss S."/>
<person name="Grzmil M."/>
<person name="Hemmerlein B."/>
<person name="Thelen P."/>
<person name="Schweyer S."/>
<person name="Neesen J."/>
<person name="Bubendorf L."/>
<person name="Glass A.G."/>
<person name="Jarry H."/>
<person name="Auber B."/>
<person name="Burfeind P."/>
</authorList>
<dbReference type="PubMed" id="18451096"/>
<dbReference type="DOI" id="10.1210/me.2006-0546"/>
</citation>
<scope>INTERACTION WITH LPXN</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3292" last="3300">
<title>ZIP kinase plays a crucial role in androgen receptor-mediated transcription.</title>
<authorList>
<person name="Leister P."/>
<person name="Felten A."/>
<person name="Chasan A.I."/>
<person name="Scheidtmann K.H."/>
</authorList>
<dbReference type="PubMed" id="18084323"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210995"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZIPK/DAPK3</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1793" first="1828" last="1836">
<title>TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.</title>
<authorList>
<person name="Kikuchi M."/>
<person name="Okumura F."/>
<person name="Tsukiyama T."/>
<person name="Watanabe M."/>
<person name="Miyajima N."/>
<person name="Tanaka J."/>
<person name="Imamura M."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="19909775"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2009.11.001"/>
</citation>
<scope>INTERACTION WITH TRIM24</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="Cancer Cell" volume="15" first="270" last="282">
<title>Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.</title>
<authorList>
<person name="Xu K."/>
<person name="Shimelis H."/>
<person name="Linn D.E."/>
<person name="Jiang R."/>
<person name="Yang X."/>
<person name="Sun F."/>
<person name="Guo Z."/>
<person name="Chen H."/>
<person name="Li W."/>
<person name="Chen H."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Fang S."/>
<person name="Xiao Z."/>
<person name="Veenstra T.D."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="19345326"/>
<dbReference type="DOI" id="10.1016/j.ccr.2009.02.021"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>POLYUBIQUITINATION AT LYS-845 AND LYS-847 BY RNF6</scope>
<scope>MUTAGENESIS OF LYS-845 AND LYS-847</scope>
<scope>INTERACTION WITH RNF14 AND RNF6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="Mol. Endocrinol." volume="24" first="2267" last="2280">
<title>CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.</title>
<authorList>
<person name="Gordon V."/>
<person name="Bhadel S."/>
<person name="Wunderlich W."/>
<person name="Zhang J."/>
<person name="Ficarro S.B."/>
<person name="Mollah S.A."/>
<person name="Shabanowitz J."/>
<person name="Hunt D.F."/>
<person name="Xenarios I."/>
<person name="Hahn W.C."/>
<person name="Conaway M."/>
<person name="Carey M.F."/>
<person name="Gioeli D."/>
</authorList>
<dbReference type="PubMed" id="20980437"/>
<dbReference type="DOI" id="10.1210/me.2010-0238"/>
</citation>
<scope>FUNCTION IN AR KINASE</scope>
<scope>PHOSPHORYLATION AT SER-81 BY CDK9</scope>
<scope>MUTAGENESIS OF SER-81</scope>
<scope>INTERACTION WITH CDK9</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="844" last="854">
<title>The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling.</title>
<authorList>
<person name="Dirac A.M."/>
<person name="Bernards R."/>
</authorList>
<dbReference type="PubMed" id="20501646"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-09-0424"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION</scope>
<scope>INTERACTION WITH USP26</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Prostate" volume="70" first="1274" last="1285">
<title>Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.</title>
<authorList>
<person name="Mahajan K."/>
<person name="Challa S."/>
<person name="Coppola D."/>
<person name="Lawrence H."/>
<person name="Luo Y."/>
<person name="Gevariya H."/>
<person name="Zhu W."/>
<person name="Chen Y.A."/>
<person name="Lawrence N.J."/>
<person name="Mahajan N.P."/>
</authorList>
<dbReference type="PubMed" id="20623637"/>
<dbReference type="DOI" id="10.1002/pros.21163"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-267</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="4303" last="4313">
<title>MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.</title>
<authorList>
<person name="Cinar B."/>
<person name="Collak F.K."/>
<person name="Lopez D."/>
<person name="Akgul S."/>
<person name="Mukhopadhyay N.K."/>
<person name="Kilicarslan M."/>
<person name="Gioeli D.G."/>
<person name="Freeman M.R."/>
</authorList>
<dbReference type="PubMed" id="21512132"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-4532"/>
</citation>
<scope>PHOSPHORYLATION AT SER-650</scope>
<scope>INTERACTION WITH STK4/MST1</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="Nature" volume="480" first="552" last="556">
<title>Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.</title>
<authorList>
<person name="Lamia K.A."/>
<person name="Papp S.J."/>
<person name="Yu R.T."/>
<person name="Barish G.D."/>
<person name="Uhlenhaut N.H."/>
<person name="Jonker J.W."/>
<person name="Downes M."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="22170608"/>
<dbReference type="DOI" id="10.1038/nature10700"/>
</citation>
<scope>INTERACTION WITH CRY1</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="188" last="199">
<title>DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors.</title>
<authorList>
<person name="Pedram A."/>
<person name="Razandi M."/>
<person name="Deschenes R.J."/>
<person name="Levin E.R."/>
</authorList>
<dbReference type="PubMed" id="22031296"/>
<dbReference type="DOI" id="10.1091/mbc.E11-07-0638"/>
</citation>
<scope>PALMITOYLATION</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="26164" last="26171">
<title>Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.</title>
<authorList>
<person name="Matias P.M."/>
<person name="Donner P."/>
<person name="Coelho R."/>
<person name="Thomaz M."/>
<person name="Peixoto C."/>
<person name="Macedo S."/>
<person name="Otto N."/>
<person name="Joschko S."/>
<person name="Scholz P."/>
<person name="Wegg A."/>
<person name="Baesler S."/>
<person name="Schaefer M."/>
<person name="Egner U."/>
<person name="Carrondo M.A."/>
</authorList>
<dbReference type="PubMed" id="10840043"/>
<dbReference type="DOI" id="10.1074/jbc.M004571200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 657-919</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2002" name="J. Med. Chem." volume="45" first="1439" last="1446">
<title>Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer.</title>
<authorList>
<person name="Matias P.M."/>
<person name="Carrondo M.A."/>
<person name="Coelho R."/>
<person name="Thomaz M."/>
<person name="Zhao X.Y."/>
<person name="Wegg A."/>
<person name="Crusius K."/>
<person name="Egner U."/>
<person name="Donner P."/>
</authorList>
<dbReference type="PubMed" id="11906285"/>
<dbReference type="DOI" id="10.1021/jm011072j"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 670-917</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2004" name="Mol. Cell" volume="16" first="425" last="438">
<title>Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.</title>
<authorList>
<person name="He B."/>
<person name="Gampe R.T. Jr."/>
<person name="Kole A.J."/>
<person name="Hnat A.T."/>
<person name="Stanley T.B."/>
<person name="An G."/>
<person name="Stewart E.L."/>
<person name="Kalman R.I."/>
<person name="Minges J.T."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="15525515"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.09.036"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 671-919 IN COMPLEXES WITH N-TERMINAL MODULATING DOMAIN AND NCOA2</scope>
<scope>INTERACTION WITH NCOA1</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER M-730</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="8060" last="8068">
<title>The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.</title>
<authorList>
<person name="Estebanez-Perpina E."/>
<person name="Moore J.M.R."/>
<person name="Mar E."/>
<person name="Delgado-Rodrigues E."/>
<person name="Nguyen P."/>
<person name="Baxter J.D."/>
<person name="Buehrer B.M."/>
<person name="Webb P."/>
<person name="Fletterick R.J."/>
<person name="Guy R.K."/>
</authorList>
<dbReference type="PubMed" id="15563469"/>
<dbReference type="DOI" id="10.1074/jbc.M407046200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF 669-919 IN COMPLEXES WITH DIHYDROTESTOSTERONE AND NCOA1; NCOA2; NCOA3 AND NCOA4</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCOA1; NCOA2; NCOA3 AND NCOA4</scope>
<scope>MUTAGENESIS OF LYS-720 AND GLU-897</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37747" last="37754">
<title>Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.</title>
<authorList>
<person name="Bohl C.E."/>
<person name="Miller D.D."/>
<person name="Chen J."/>
<person name="Bell C.E."/>
<person name="Dalton J.T."/>
</authorList>
<dbReference type="PubMed" id="16129672"/>
<dbReference type="DOI" id="10.1074/jbc.M507464200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 664-919 IN COMPLEXES WITH NONSTEROIDAL LIGANDS</scope>
<scope>MUTAGENESIS OF TRP-741</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER ALA-877</scope>
<scope>CHARACTERIZATION OF VARIANT AIS THR-895</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2006" name="Protein Sci." volume="15" first="987" last="999">
<title>Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity.</title>
<authorList>
<person name="Pereira de Jesus-Tran K."/>
<person name="Cote P.-L."/>
<person name="Cantin L."/>
<person name="Blanchet J."/>
<person name="Labrie F."/>
<person name="Breton R."/>
</authorList>
<dbReference type="PubMed" id="16641486"/>
<dbReference type="DOI" id="10.1110/ps.051905906"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF 654-919 IN COMPLEXES WITH TESTOSTERONE; DIHYDROTESTOSTERONE AND TETRAHYDROGESTRINONE</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2007" name="Acta Crystallogr. D" volume="63" first="1198" last="1200">
<title>Interaction between the androgen receptor and a segment of its corepressor SHP.</title>
<authorList>
<person name="Jouravel N."/>
<person name="Sablin E."/>
<person name="Arnold L.A."/>
<person name="Guy R.K."/>
<person name="Fletterick R.J."/>
</authorList>
<dbReference type="PubMed" id="18007036"/>
<dbReference type="DOI" id="10.1107/S0907444907045702"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 671-918 IN COMPLEX WITH NR0B2</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="13648" last="13655">
<title>Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design.</title>
<authorList>
<person name="Bohl C.E."/>
<person name="Wu Z."/>
<person name="Miller D.D."/>
<person name="Bell C.E."/>
<person name="Dalton J.T."/>
</authorList>
<dbReference type="PubMed" id="17311914"/>
<dbReference type="DOI" id="10.1074/jbc.M611711200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 671-919 OF MUTANT ALA-877 IN COMPLEX WITH THE ANTIANDROGEN CYPROTERONE ACETATE</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER ALA-877</scope>
<scope>MUTAGENESIS OF LEU-701</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="25801" last="25816">
<title>Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.</title>
<authorList>
<person name="Askew E.B."/>
<person name="Gampe R.T. Jr."/>
<person name="Stanley T.B."/>
<person name="Faggart J.L."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="17591767"/>
<dbReference type="DOI" id="10.1074/jbc.M703268200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 663-919 OF WILD-TYPE AND MUTANT TYR-874 IN COMPLEX WITH TESTOSTERONE AND NCOA2</scope>
<scope>ACTIVATION BY THE N-TERMINAL MODULATING DOMAIN</scope>
<scope>INTERACTION WITH NCOA2 AND MAGEA11</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-720 AND GLU-897</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER TYR-874</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="30910" last="30919">
<title>Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12.</title>
<authorList>
<person name="Cantin L."/>
<person name="Faucher F."/>
<person name="Couture J.-F."/>
<person name="de Jesus-Tran K.P."/>
<person name="Legrand P."/>
<person name="Ciobanu L.C."/>
<person name="Frechette Y."/>
<person name="Labrecque R."/>
<person name="Singh S.M."/>
<person name="Labrie F."/>
<person name="Breton R."/>
</authorList>
<dbReference type="PubMed" id="17711855"/>
<dbReference type="DOI" id="10.1074/jbc.M705524200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 654-919 IN COMPLEX WITH EM5744</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="16074" last="16079">
<title>A surface on the androgen receptor that allosterically regulates coactivator binding.</title>
<authorList>
<person name="Estebanez-Perpina E."/>
<person name="Arnold L.A."/>
<person name="Nguyen P."/>
<person name="Rodrigues E.D."/>
<person name="Mar E."/>
<person name="Bateman R."/>
<person name="Pallai P."/>
<person name="Shokat K.M."/>
<person name="Baxter J.D."/>
<person name="Guy R.K."/>
<person name="Webb P."/>
<person name="Fletterick R.J."/>
</authorList>
<dbReference type="PubMed" id="17911242"/>
<dbReference type="DOI" id="10.1073/pnas.0708036104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS) OF 669-919 IN COMPLEXES WITH SYNTHETIC LIGANDS</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCOA2</scope>
</reference>
<reference key="69">
<citation type="journal article" date="1992" name="Clin. Invest. Med." volume="15" first="456" last="472">
<title>Androgen resistance due to mutation of the androgen receptor.</title>
<authorList>
<person name="Pinsky L."/>
<person name="Trifiro M.A."/>
<person name="Kaufman M."/>
<person name="Beitel L.K."/>
<person name="Mhatre A."/>
<person name="Kazemi-Esfarjani P."/>
<person name="Sabbaghian N."/>
<person name="Lumbroso R."/>
<person name="Alvarado C."/>
<person name="Vasiliou M."/>
<person name="Gottlieb B."/>
</authorList>
<dbReference type="PubMed" id="1458719"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="70">
<citation type="journal article" date="1993" name="Eur. J. Pediatr. 152 Suppl." volume="2" first="S62" last="S69">
<title>Molecular genetics of human androgen insensitivity.</title>
<authorList>
<person name="Brown T.R."/>
<person name="Scherer P.A."/>
<person name="Chang Y.-T."/>
<person name="Migeon C.J."/>
<person name="Ghirri P."/>
<person name="Murono K."/>
<person name="Zhou Z."/>
</authorList>
<dbReference type="PubMed" id="8339746"/>
<dbReference type="DOI" id="10.1007/BF02125442"/>
</citation>
<scope>REVIEW ON VARIANTS AIS</scope>
</reference>
<reference key="71">
<citation type="journal article" date="1993" name="J. Steroid Biochem. Mol. Biol." volume="46" first="519" last="530">
<title>Mutations of androgen receptor gene in androgen insensitivity syndromes.</title>
<authorList>
<person name="Sultan C."/>
<person name="Lumbroso S."/>
<person name="Poujol N."/>
<person name="Belon C."/>
<person name="Boudon C."/>
<person name="Lobaccaro J.-M."/>
</authorList>
<dbReference type="PubMed" id="8240973"/>
<dbReference type="DOI" id="10.1016/0960-0760(93)90178-Y"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1994" name="Nucleic Acids Res." volume="22" first="3560" last="3562">
<title>The androgen receptor gene mutations database.</title>
<authorList>
<person name="Patterson M.N."/>
<person name="Hughes I.A."/>
<person name="Gottlieb B."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="7937057"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="73">
<citation type="journal article" date="1995" name="J. Steroid Biochem. Mol. Biol." volume="53" first="443" last="448">
<title>Androgen receptor mutations.</title>
<authorList>
<person name="Brinkmann A.O."/>
<person name="Jenster G."/>
<person name="Ris-Stalpers C."/>
<person name="van der Korput J.A.G.M."/>
<person name="Bruggenwirth H.T."/>
<person name="Boehmer A.L.M."/>
<person name="Trapman J."/>
</authorList>
<dbReference type="PubMed" id="7626493"/>
<dbReference type="DOI" id="10.1016/0960-0760(95)00090-M"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="74">
<citation type="journal article" date="1997" name="Nucleic Acids Res." volume="25" first="158" last="162">
<title>The androgen receptor gene mutations database.</title>
<authorList>
<person name="Gottlieb B."/>
<person name="Trifiro M.A."/>
<person name="Lumbroso R."/>
<person name="Vasiliou D.M."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="9016528"/>
<dbReference type="DOI" id="10.1093/nar/25.1.158"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="887" last="894">
<title>The androgen receptor gene mutations database: 2012 update.</title>
<authorList>
<person name="Gottlieb B."/>
<person name="Beitel L.K."/>
<person name="Nadarajah A."/>
<person name="Paliouras M."/>
<person name="Trifiro M."/>
</authorList>
<dbReference type="PubMed" id="22334387"/>
<dbReference type="DOI" id="10.1002/humu.22046"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="173" first="534" last="540">
<title>A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.</title>
<authorList>
<person name="Veldscholte J."/>
<person name="Ris-Stalpers C."/>
<person name="Kuiper G.G.J.M."/>
<person name="Jenster G."/>
<person name="Berrevoets C.A."/>
<person name="Claassen E."/>
<person name="van Rooij H.C.J."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
<person name="Mulder E."/>
</authorList>
<dbReference type="PubMed" id="2260966"/>
<dbReference type="DOI" id="10.1016/S0006-291X(05)80067-1"/>
</citation>
<scope>VARIANT LNCAP ALA-877</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="1759" last="1772">
<title>Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity.</title>
<authorList>
<person name="Brown T.R."/>
<person name="Lubahn D.B."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
<person name="Migeon C.J."/>
<person name="Corfen J.L."/>
</authorList>
<dbReference type="PubMed" id="2082179"/>
<dbReference type="DOI" id="10.1210/mend-4-12-1759"/>
</citation>
<scope>VARIANTS AIS CYS-774; GLN-831 AND MET-866</scope>
</reference>
<reference key="78">
<citation type="journal article" date="1991" name="J. Clin. Endocrinol. Metab." volume="73" first="318" last="325">
<title>Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-->Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Tilley W.D."/>
<person name="Zoppi S."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1856263"/>
<dbReference type="DOI" id="10.1210/jcem-73-2-318"/>
</citation>
<scope>VARIANT CYS-774</scope>
</reference>
<reference key="79">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="1123" last="1126">
<title>A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="Grino P.B."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1999491"/>
<dbReference type="DOI" id="10.1172/JCI115076"/>
</citation>
<scope>VARIANT AIS PRO-617</scope>
</reference>
<reference key="80">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="1413" last="1421">
<title>Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy.</title>
<authorList>
<person name="McPhaul M.J."/>
<person name="Marcelli M."/>
<person name="Tilley W.D."/>
<person name="Griffin J.E."/>
<person name="Isidro-Gutierrez R.F."/>
<person name="Wilson J.D."/>
</authorList>
<dbReference type="PubMed" id="2010552"/>
<dbReference type="DOI" id="10.1172/JCI115147"/>
</citation>
<scope>VARIANT PAIS CYS-763</scope>
</reference>
<reference key="81">
<citation type="journal article" date="1991" name="Nature" volume="352" first="77" last="79">
<title>Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.</title>
<authorList>
<person name="la Spada A.R."/>
<person name="Wilson E.M."/>
<person name="Lubahn D.B."/>
<person name="Harding A.E."/>
<person name="Fischbeck K.H."/>
</authorList>
<dbReference type="PubMed" id="2062380"/>
<dbReference type="DOI" id="10.1038/352077a0"/>
</citation>
<scope>POLY-GLN REGION EXPANSION</scope>
<scope>INVOLVEMENT IN SPINAL AND BULBAR MUSCULAR ATROPHY</scope>
</reference>
<reference key="82">
<citation type="journal article" date="1992" name="Am. J. Hum. Genet." volume="51" first="143" last="155">
<title>Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.</title>
<authorList>
<person name="Prior L."/>
<person name="Bordet S."/>
<person name="Trifiro M.A."/>
<person name="Mhatre A."/>
<person name="Kaufman M."/>
<person name="Pinsky L."/>
<person name="Wrogemann K."/>
<person name="Belsham D.D."/>
<person name="Pereira F."/>
<person name="Greenberg C.R."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
<person name="Chang C."/>
<person name="Liao S."/>
</authorList>
<dbReference type="PubMed" id="1609793"/>
</citation>
<scope>VARIANTS AIS CYS-774 AND HIS-774</scope>
</reference>
<reference key="83">
<citation type="journal article" date="1992" name="Clin. Endocrinol. (Oxf.)" volume="37" first="214" last="220">
<title>Point mutations detected in the androgen receptor gene of three men with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Saunders P.T."/>
<person name="Padayachi T."/>
<person name="Tincello D.G."/>
<person name="Shalet S.M."/>
<person name="Wu F.C."/>
</authorList>
<dbReference type="PubMed" id="1424203"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.1992.tb02313.x"/>
</citation>
<scope>VARIANTS PAIS LYS-608 AND LEU-866</scope>
</reference>
<reference key="84">
<citation type="journal article" date="1992" name="Fertil. Steril." volume="58" first="703" last="707">
<title>A unique point mutation in the androgen receptor gene in a family with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Sweet C.R."/>
<person name="Behzadian M.A."/>
<person name="McDonough P.G."/>
</authorList>
<dbReference type="PubMed" id="1426313"/>
</citation>
<scope>VARIANT AIS THR-765</scope>
</reference>
<reference key="85">
<citation type="journal article" date="1992" name="Hum. Genet." volume="90" first="311" last="312">
<title>Point mutation in the steroid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome (CAIS).</title>
<authorList>
<person name="Jakubiczka S."/>
<person name="Werder E.A."/>
<person name="Wieacker P."/>
</authorList>
<dbReference type="PubMed" id="1487249"/>
<dbReference type="DOI" id="10.1007/BF00220088"/>
</citation>
<scope>VARIANT AIS VAL-749</scope>
</reference>
<reference key="86">
<citation type="journal article" date="1992" name="Hum. Mol. Genet." volume="1" first="497" last="503">
<title>Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome.</title>
<authorList>
<person name="Batch J.A."/>
<person name="Williams D.M."/>
<person name="Davies H.R."/>
<person name="Brown B.D."/>
<person name="Evans B.A.J."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="1307250"/>
<dbReference type="DOI" id="10.1093/hmg/1.7.497"/>
</citation>
<scope>VARIANTS AIS</scope>
<scope>VARIANTS PAIS</scope>
</reference>
<reference key="87">
<citation type="journal article" date="1992" name="J. Clin. Endocrinol. Metab." volume="74" first="1152" last="1157">
<title>A single amino acid substitution (Met-786-->Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Nakao R."/>
<person name="Haji M."/>
<person name="Yanase T."/>
<person name="Ogo A."/>
<person name="Takayanagi R."/>
<person name="Katsube T."/>
<person name="Fukumaki Y."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="1569163"/>
<dbReference type="DOI" id="10.1210/jc.74.5.1152"/>
</citation>
<scope>VARIANT AIS VAL-787</scope>
</reference>
<reference key="88">
<citation type="journal article" date="1992" name="J. Clin. Endocrinol. Metab." volume="75" first="1474" last="1478">
<title>Immunoreactive androgen receptor expression in subjects with androgen resistance.</title>
<authorList>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1464650"/>
<dbReference type="DOI" id="10.1210/jc.75.6.1474"/>
</citation>
<scope>VARIANTS AIS ARG-741 AND CYS-834</scope>
</reference>
<reference key="89">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="90" first="2097" last="2101">
<title>Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.</title>
<authorList>
<person name="McPhaul M.J."/>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
</authorList>
<dbReference type="PubMed" id="1430233"/>
<dbReference type="DOI" id="10.1172/JCI116093"/>
</citation>
<scope>VARIANTS AIS</scope>
<scope>VARIANTS PAIS</scope>
</reference>
<reference key="90">
<citation type="journal article" date="1992" name="J. Steroid Biochem. Mol. Biol." volume="41" first="665" last="669">
<title>The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.</title>
<authorList>
<person name="Veldscholte J."/>
<person name="Berrevoets C.A."/>
<person name="Ris-Stalpers C."/>
<person name="Kuiper G.G.J.M."/>
<person name="Jenster G."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
<person name="Mulder E."/>
</authorList>
<dbReference type="PubMed" id="1562539"/>
<dbReference type="DOI" id="10.1016/0960-0760(92)90401-4"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-877</scope>
</reference>
<reference key="91">
<citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="409" last="415">
<title>Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance.</title>
<authorList>
<person name="Zoppi S."/>
<person name="Marcelli M."/>
<person name="Deslypere J.-P."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1316540"/>
<dbReference type="DOI" id="10.1210/me.6.3.409"/>
</citation>
<scope>VARIANTS AIS TYR-559 AND ARG-576</scope>
<scope>VARIANTS PAIS GLY-597 AND PRO-617</scope>
</reference>
<reference key="92">
<citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="1909" last="1920">
<title>Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.</title>
<authorList>
<person name="De Bellis A."/>
<person name="Quigley C.A."/>
<person name="Cariello N.F."/>
<person name="el-Awady M.K."/>
<person name="Sar M."/>
<person name="Lane M.V."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="1480178"/>
<dbReference type="DOI" id="10.1210/me.6.11.1909"/>
</citation>
<scope>VARIANTS AIS SER-705; VAL-749; PHE-759; HIS-774; CYS-855 AND GLY-864</scope>
</reference>
<reference key="93">
<citation type="journal article" date="1992" name="Nat. Genet." volume="2" first="132" last="134">
<title>A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.</title>
<authorList>
<person name="Wooster R."/>
<person name="Mangion J."/>
<person name="Eeles R."/>
<person name="Smith S."/>
<person name="Dowsett M."/>
<person name="Averill D."/>
<person name="Barrett-Lee P."/>
<person name="Easton D.F."/>
<person name="Ponder B.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="1303262"/>
<dbReference type="DOI" id="10.1038/ng1092-132"/>
</citation>
<scope>VARIANT PAIS/BREAST CANCER GLN-607</scope>
</reference>
<reference key="94">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="6319" last="6323">
<title>Androgen receptor gene mutations in human prostate cancer.</title>
<authorList>
<person name="Newmark J.R."/>
<person name="Hardy D.O."/>
<person name="Tonb D.C."/>
<person name="Carter B.S."/>
<person name="Epstein J.I."/>
<person name="Isaacs W.B."/>
<person name="Brown T.R."/>
<person name="Barrack E.R."/>
</authorList>
<dbReference type="PubMed" id="1631125"/>
<dbReference type="DOI" id="10.1073/pnas.89.14.6319"/>
</citation>
<scope>VARIANT MET-730</scope>
</reference>
<reference key="95">
<citation type="journal article" date="1993" name="Am. J. Hum. Genet." volume="53" first="844" last="852">
<title>Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation.</title>
<authorList>
<person name="Macke J.P."/>
<person name="Hu N."/>
<person name="Hu S."/>
<person name="Bailey M."/>
<person name="King V.L."/>
<person name="Brown T."/>
<person name="Hamer D."/>
<person name="Nathans J."/>
</authorList>
<dbReference type="PubMed" id="8213813"/>
</citation>
<scope>VARIANTS ARG-205 AND ASP-793</scope>
</reference>
<reference key="96">
<citation type="journal article" date="1993" name="Fertil. Steril." volume="60" first="814" last="819">
<title>A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Lumbroso S."/>
<person name="Lobaccaro J.-M."/>
<person name="Belon C."/>
<person name="Martin D."/>
<person name="Chaussain J.-L."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8224266"/>
</citation>
<scope>VARIANT AIS PHE-581</scope>
</reference>
<reference key="97">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1041" last="1043">
<title>An exonic point mutation creates a MaeIII site in the androgen receptor gene of a family with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Ktari R."/>
<person name="Dumas R."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8103398"/>
<dbReference type="DOI" id="10.1093/hmg/2.7.1041"/>
</citation>
<scope>VARIANT AIS VAL-754</scope>
</reference>
<reference key="98">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1799" last="1802">
<title>Androgen receptor gene mutation in male breast cancer.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Belon C."/>
<person name="Galtier-Dereure F."/>
<person name="Bringer J."/>
<person name="Lesimple T."/>
<person name="Namer M."/>
<person name="Cutuli B.F."/>
<person name="Pujol H."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8281139"/>
<dbReference type="DOI" id="10.1093/hmg/2.11.1799"/>
</citation>
<scope>VARIANT PAIS/BREAST CANCER LYS-608</scope>
</reference>
<reference key="99">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1809" last="1812">
<title>A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro.</title>
<authorList>
<person name="Adeyemo O."/>
<person name="Kallio P.J."/>
<person name="Palvimo J.J."/>
<person name="Kontula K."/>
<person name="Jaenne O.A."/>
</authorList>
<dbReference type="PubMed" id="8281140"/>
<dbReference type="DOI" id="10.1093/hmg/2.11.1809"/>
</citation>
<scope>VARIANT AIS ARG-807</scope>
</reference>
<reference key="100">
<citation type="journal article" date="1993" name="J. Clin. Endocrinol. Metab." volume="77" first="103" last="107">
<title>A single amino acid substitution (Gly743 --> Val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome.</title>
<authorList>
<person name="Nakao R."/>
<person name="Yanase T."/>
<person name="Sakai Y."/>
<person name="Haji M."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8325932"/>
<dbReference type="DOI" id="10.1210/jcem.77.1.8325932"/>
</citation>
<scope>VARIANT PAIS VAL-743</scope>
</reference>
<reference key="101">
<citation type="journal article" date="1993" name="J. Clin. Endocrinol. Metab." volume="77" first="262" last="266">
<title>Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy.</title>
<authorList>
<person name="Hiort O."/>
<person name="Huang Q."/>
<person name="Sinnecker G.H."/>
<person name="Sadeghi-Nejad A."/>
<person name="Kruse K."/>
<person name="Wolfe H.J."/>
<person name="Yandell D.W."/>
</authorList>
<dbReference type="PubMed" id="8325950"/>
<dbReference type="DOI" id="10.1210/jc.77.1.262"/>
</citation>
<scope>VARIANTS AIS LYS-681 AND THR-842</scope>
<scope>VARIANTS PAIS HIS-840 AND LEU-866</scope>
</reference>
<reference key="102">
<citation type="journal article" date="1993" name="J. Med. Genet." volume="30" first="198" last="201">
<title>Mutations of the androgen receptor gene identified in perineal hypospadias.</title>
<authorList>
<person name="Batch J.A."/>
<person name="Evans B.A.J."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="8097257"/>
<dbReference type="DOI" id="10.1136/jmg.30.3.198"/>
</citation>
<scope>VARIANTS PAIS HIS-855 AND MET-869</scope>
</reference>
<reference key="103">
<citation type="journal article" date="1993" name="J. Steroid Biochem. Mol. Biol." volume="44" first="211" last="216">
<title>Complete androgen insensitivity syndrome associated with a de novo mutation of the androgen receptor gene detected by single strand conformation polymorphism.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Berta P."/>
<person name="Chaussain J.-L."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8096390"/>
<dbReference type="DOI" id="10.1016/0960-0760(93)90081-7"/>
</citation>
<scope>VARIANT AIS VAL-743</scope>
</reference>
<reference key="104">
<citation type="journal article" date="1993" name="J. Steroid Biochem. Mol. Biol." volume="46" first="759" last="765">
<title>Androgen receptor gene mutations in human prostate cancer.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Sato N."/>
<person name="Watabe Y."/>
<person name="Masai M."/>
<person name="Seino S."/>
<person name="Shimazaki J."/>
</authorList>
<dbReference type="PubMed" id="8274409"/>
<dbReference type="DOI" id="10.1016/0960-0760(93)90316-O"/>
</citation>
<scope>VARIANTS PROSTATE CANCER HIS-701 AND ALA-877</scope>
</reference>
<reference key="105">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="37" last="46">
<title>Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.</title>
<authorList>
<person name="Kazemi-Esfarjani P."/>
<person name="Beitel L.K."/>
<person name="Trifiro M.A."/>
<person name="Kaufman M."/>
<person name="Rennie P."/>
<person name="Sheppard P."/>
<person name="Matusik R."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="8446106"/>
<dbReference type="DOI" id="10.1210/me.7.1.37"/>
</citation>
<scope>VARIANT AIS MET-866</scope>
<scope>VARIANT PAIS LEU-866</scope>
</reference>
<reference key="106">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="1541" last="1550">
<title>Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.</title>
<authorList>
<person name="Culig Z."/>
<person name="Hobisch A."/>
<person name="Cronauer M.V."/>
<person name="Cato A.C.B."/>
<person name="Hittmair A."/>
<person name="Radmayr C."/>
<person name="Eberle J."/>
<person name="Bartsch G."/>
<person name="Klocker H."/>
</authorList>
<dbReference type="PubMed" id="8145761"/>
<dbReference type="DOI" id="10.1210/me.7.12.1541"/>
</citation>
<scope>VARIANT PROSTATE CANCER MET-715</scope>
</reference>
<reference key="107">
<citation type="journal article" date="1993" name="Pediatr. Res. Suppl." volume="33" first="S22" last="S22">
<title>Androgen receptor (AR) gene mutations in 6 families with androgen insensitivity syndrome (Abstract #114).</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Belon C."/>
<person name="Chaussain J.L."/>
<person name="Toublanc J.E."/>
<person name="Leheup B."/>
<person name="Sultan C."/>
</authorList>
</citation>
<scope>VARIANTS AIS PHE-581; VAL-743; VAL-754; GLU-767 AND CYS-855</scope>
</reference>
<reference key="108">
<citation type="journal article" date="1993" name="Verh. Dtsch. Ges. Pathol." volume="77" first="119" last="123">
<title>Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer.</title>
<authorList>
<person name="Castagnaro M."/>
<person name="Yandell D.W."/>
<person name="Dockhorn-Dworniczak B."/>
<person name="Wolfe H.J."/>
<person name="Poremba C."/>
</authorList>
<dbReference type="PubMed" id="7511268"/>
</citation>
<scope>VARIANTS PROSTATE CANCER LEU-340 AND GLU-798</scope>
</reference>
<reference key="109">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="198" first="74" last="80">
<title>Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.</title>
<authorList>
<person name="Schoenberg M.P."/>
<person name="Hakimi J.M."/>
<person name="Wang S."/>
<person name="Bova G.S."/>
<person name="Epstein J.I."/>
<person name="Fischbeck K.H."/>
<person name="Isaacs W.B."/>
<person name="Walsh P.C."/>
<person name="Barrack E.R."/>
</authorList>
<dbReference type="PubMed" id="8292051"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.1011"/>
</citation>
<scope>POLY-GLN REGION CONTRACTION</scope>
<scope>INVOLVEMENT IN PROSTATE CANCER</scope>
</reference>
<reference key="110">
<citation type="journal article" date="1994" name="Cancer Res." volume="54" first="2861" last="2864">
<title>Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.</title>
<authorList>
<person name="Gaddipati J.P."/>
<person name="McLeod D.G."/>
<person name="Heidenberg H.B."/>
<person name="Sesterhenn I.A."/>
<person name="Finger M.J."/>
<person name="Moul J.W."/>
<person name="Srivastava S."/>
</authorList>
<dbReference type="PubMed" id="8187068"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-877</scope>
</reference>
<reference key="111">
<citation type="journal article" date="1994" name="Clin. Endocrinol. (Oxf.)" volume="40" first="297" last="302">
<title>Molecular prenatal diagnosis of partial androgen insensitivity syndrome based on the Hind III polymorphism of the androgen receptor gene.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Belon C."/>
<person name="Lumbroso S."/>
<person name="Olewniczack G."/>
<person name="Carre-Pigeon F."/>
<person name="Job J.C."/>
<person name="Chaussain J.L."/>
<person name="Toublanc J.E."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="7910529"/>
</citation>
<scope>VARIANT PAIS TRP-568</scope>
</reference>
<reference key="112">
<citation type="journal article" date="1994" name="Eur. J. Endocrinol." volume="130" first="327" last="332">
<title>Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome).</title>
<authorList>
<person name="Lumbroso S."/>
<person name="Lobaccaro J.-M."/>
<person name="Belon C."/>
<person name="Amram S."/>
<person name="Bachelard B."/>
<person name="Garandeau P."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="7909256"/>
<dbReference type="DOI" id="10.1530/eje.0.1300327"/>
</citation>
<scope>VARIANT PAIS HIS-840</scope>
</reference>
<reference key="113">
<citation type="journal article" date="1994" name="Eur. J. Endocrinol." volume="130" first="569" last="574">
<title>Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor.</title>
<authorList>
<person name="Imasaki K."/>
<person name="Hasegawa T."/>
<person name="Okabe T."/>
<person name="Sakai Y."/>
<person name="Haji M."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8205256"/>
<dbReference type="DOI" id="10.1530/eje.0.1300569"/>
</citation>
<scope>VARIANT PAIS HIS-840</scope>
</reference>
<reference key="114">
<citation type="journal article" date="1994" name="Eur. J. Pediatr." volume="153" first="317" last="321">
<title>Molecular characterization of the androgen receptor gene in boys with hypospadias.</title>
<authorList>
<person name="Hiort O."/>
<person name="Klauber G."/>
<person name="Cendron M."/>
<person name="Sinnecker G.H."/>
<person name="Keim L."/>
<person name="Schwinger E."/>
<person name="Wolfe H.J."/>
<person name="Yandell D.W."/>
</authorList>
<dbReference type="PubMed" id="8033918"/>
<dbReference type="DOI" id="10.1007/BF01956409"/>
</citation>
<scope>VARIANT PAIS VAL-870</scope>
</reference>
<reference key="115">
<citation type="journal article" date="1994" name="Horm. Res." volume="41" first="117" last="117">
<title>Partial androgen insensitivity (PAIS) in a large eskimo kindred caused by a delD690 mutation in the androgen receptor (AR) gene (Abstract #244).</title>
<authorList>
<person name="Schwartz M."/>
<person name="Skovby F."/>
<person name="Mueller J."/>
<person name="Nielsen O."/>
<person name="Skakkebaek N.E."/>
</authorList>
</citation>
<scope>VARIANT PAIS ASP-690 DEL</scope>
</reference>
<reference key="116">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="21" last="27">
<title>Complete androgen insensitivity due to mutations in the probable alpha-helical segments of the DNA-binding domain in the human androgen receptor.</title>
<authorList>
<person name="Beitel L.K."/>
<person name="Prior L."/>
<person name="Vasiliou D.M."/>
<person name="Gottlieb B."/>
<person name="Kaufman M."/>
<person name="Lumbroso R."/>
<person name="Alvarado C."/>
<person name="McGillivray B."/>
<person name="Trifiro M.A."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="8162033"/>
<dbReference type="DOI" id="10.1093/hmg/3.1.21"/>
</citation>
<scope>VARIANTS AIS PHE-582 DEL; ARG-615 DEL AND HIS-615</scope>
</reference>
<reference key="117">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1163" last="1166">
<title>Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis.</title>
<authorList>
<person name="Hiort O."/>
<person name="Wodtke A."/>
<person name="Struve D."/>
<person name="Zoellner A."/>
<person name="Sinnecker G.H."/>
</authorList>
<dbReference type="PubMed" id="7981687"/>
<dbReference type="DOI" id="10.1093/hmg/3.7.1163"/>
</citation>
<scope>VARIANTS PAIS SER-582; TYR-604; ALA-708; LEU-754 AND HIS-771</scope>
<scope>VARIANT AIS TRP-779</scope>
</reference>
<reference key="118">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1169" last="1170">
<title>Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys-->Phe substitution in the second zinc finger of the androgen receptor.</title>
<authorList>
<person name="Baldazzi L."/>
<person name="Baroncini C."/>
<person name="Pirazzoli P."/>
<person name="Balsamo A."/>
<person name="Capelli M."/>
<person name="Marchetti G."/>
<person name="Bernardi F."/>
<person name="Cacciari E."/>
</authorList>
<dbReference type="PubMed" id="7981689"/>
<dbReference type="DOI" id="10.1093/hmg/3.7.1169"/>
</citation>
<scope>VARIANT AIS PHE-601</scope>
</reference>
<reference key="119">
<citation type="journal article" date="1994" name="J. Clin. Endocrinol. Metab." volume="78" first="513" last="522">
<title>Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.</title>
<authorList>
<person name="De Bellis A."/>
<person name="Quigley C.A."/>
<person name="Marschke K.B."/>
<person name="el-Awady M.K."/>
<person name="Lane M.V."/>
<person name="Smith E.P."/>
<person name="Sar M."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="8126121"/>
<dbReference type="DOI" id="10.1210/jc.78.3.513"/>
</citation>
<scope>VARIANTS PAIS ARG-616; HIS-840 AND MET-889</scope>
</reference>
<reference key="120">
<citation type="journal article" date="1994" name="J. Clin. Endocrinol. Metab." volume="79" first="1202" last="1207">
<title>An androgen receptor mutation causing androgen resistance in undervirilized male syndrome.</title>
<authorList>
<person name="Tsukada T."/>
<person name="Inoue M."/>
<person name="Tachibana S."/>
<person name="Nakai Y."/>
<person name="Takebe H."/>
</authorList>
<dbReference type="PubMed" id="7962294"/>
<dbReference type="DOI" id="10.1210/jc.79.4.1202"/>
</citation>
<scope>VARIANT AIS PHE-790</scope>
</reference>
<reference key="121">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="94" first="546" last="554">
<title>Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.</title>
<authorList>
<person name="Beitel L.K."/>
<person name="Kazemi-Esfarjani P."/>
<person name="Kaufman M."/>
<person name="Lumbroso R."/>
<person name="DiGeorge A.M."/>
<person name="Killinger D.W."/>
<person name="Trifiro M.A."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="8040309"/>
<dbReference type="DOI" id="10.1172/JCI117368"/>
</citation>
<scope>VARIANTS AIS CYS-840 AND HIS-840</scope>
</reference>
<reference key="122">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="94" first="1642" last="1650">
<title>Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="7929841"/>
<dbReference type="DOI" id="10.1172/JCI117507"/>
</citation>
<scope>VARIANTS AIS</scope>
<scope>VARIANTS PAIS</scope>
</reference>
<reference key="123">
<citation type="journal article" date="1994" name="Lancet" volume="344" first="826" last="827">
<title>Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene.</title>
<authorList>
<person name="Yong E.L."/>
<person name="Ng S.C."/>
<person name="Roy A.C."/>
<person name="Yun G."/>
<person name="Ratnam S.S."/>
</authorList>
<dbReference type="PubMed" id="7993455"/>
<dbReference type="DOI" id="10.1016/S0140-6736(94)92385-X"/>
</citation>
<scope>VARIANT AIS LYS-727</scope>
</reference>
<reference key="124">
<citation type="journal article" date="1994" name="Pediatr. Res." volume="36" first="227" last="234">
<title>A practical approach to the detection of androgen receptor gene mutations and pedigree analysis in families with X-linked androgen insensitivity.</title>
<authorList>
<person name="Ris-Stalpers C."/>
<person name="Hoogenboezem T."/>
<person name="Sleddens H.F.B.M."/>
<person name="Verleun-Mooijman M.C.T."/>
<person name="Degenhart H.J."/>
<person name="Drop S.L.S."/>
<person name="Halley D.J.J."/>
<person name="Oosterwijk J.C."/>
<person name="Hodgins M.B."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="7970939"/>
<dbReference type="DOI" id="10.1203/00006450-199408000-00015"/>
</citation>
<scope>VARIANTS AIS HIS-615 AND LEU-764</scope>
<scope>VARIANTS PAIS VAL-742 AND THR-745</scope>
</reference>
<reference key="125">
<citation type="journal article" date="1995" name="Ann. Clin. Biochem." volume="32" first="482" last="486">
<title>A frame-shift mutation of the androgen receptor gene in a patient with receptor-negative complete testicular feminization: comparison with a single base substitution in a receptor-reduced incomplete form.</title>
<authorList>
<person name="Imai A."/>
<person name="Ohno T."/>
<person name="Iida K."/>
<person name="Ohsuye K."/>
<person name="Okano Y."/>
<person name="Tamaya T."/>
</authorList>
<dbReference type="PubMed" id="8830623"/>
</citation>
<scope>VARIANT AIS HIS-840</scope>
</reference>
<reference key="126">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="1621" last="1624">
<title>Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.</title>
<authorList>
<person name="Takahashi H."/>
<person name="Furusato M."/>
<person name="Allsbrook W.C. Jr."/>
<person name="Nishii H."/>
<person name="Wakui S."/>
<person name="Barrett J.C."/>
<person name="Boyd J."/>
</authorList>
<dbReference type="PubMed" id="7712463"/>
</citation>
<scope>VARIANTS PROSTATE CANCER</scope>
</reference>
<reference key="127">
<citation type="journal article" date="1995" name="Clin. Endocrinol. (Oxf.)" volume="43" first="69" last="77">
<title>Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene.</title>
<authorList>
<person name="Davies H.R."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="7641413"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.1995.tb01895.x"/>
</citation>
<scope>VARIANT AIS VAL-881</scope>
</reference>
<reference key="128">
<citation type="journal article" date="1995" name="Endocr. Rev." volume="16" first="271" last="321">
<title>Androgen receptor defects: historical, clinical, and molecular perspectives.</title>
<authorList>
<person name="Quigley C.A."/>
<person name="De Bellis A."/>
<person name="Marschke K.B."/>
<person name="el-Awady M.K."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="7671849"/>
<dbReference type="DOI" id="10.1210/er.16.3.271"/>
</citation>
<scope>VARIANTS AIS SER-705 AND HIS-763</scope>
<scope>VARIANTS PAIS LEU-725; THR-737; HIS-774 AND GLU-798</scope>
</reference>
<reference key="129">
<citation type="journal article" date="1995" name="Endocr. Rev." volume="16" first="546" last="546">
<authorList>
<person name="Quigley C.A."/>
<person name="De Bellis A."/>
<person name="Marschke K.B."/>
<person name="el-Awady M.K."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="130">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="515" last="521">
<title>Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families.</title>
<authorList>
<person name="Shkolny D.L."/>
<person name="Brown T.R."/>
<person name="Punnett H.H."/>
<person name="Kaufman M."/>
<person name="Trifiro M.A."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="7633398"/>
<dbReference type="DOI" id="10.1093/hmg/4.4.515"/>
</citation>
<scope>VARIANTS AIS LEU-831 AND GLN-831</scope>
</reference>
<reference key="131">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="28" last="33">
<title>Leu-676-Pro mutation of the androgen receptor causes complete androgen insensitivity syndrome in a large Hutterite kindred.</title>
<authorList>
<person name="Belsham D.D."/>
<person name="Pereira F."/>
<person name="Greenberg C.R."/>
<person name="Liao S."/>
<person name="Wrogemann K."/>
</authorList>
<dbReference type="PubMed" id="7537149"/>
<dbReference type="DOI" id="10.1002/humu.1380050104"/>
</citation>
<scope>VARIANT AIS PRO-677</scope>
</reference>
<reference key="132">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="6" first="152" last="162">
<title>Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.</title>
<authorList>
<person name="Murono K."/>
<person name="Mendonca B.B."/>
<person name="Arnhold I.J.P."/>
<person name="Rigon A.C.M.M."/>
<person name="Migeon C.J."/>
<person name="Brown T.R."/>
</authorList>
<dbReference type="PubMed" id="7581399"/>
<dbReference type="DOI" id="10.1002/humu.1380060208"/>
</citation>
<scope>VARIANT PAIS CYS-763</scope>
<scope>VARIANTS AIS TRP-779; VAL-807 AND CYS-855</scope>
</reference>
<reference key="133">
<citation type="journal article" date="1995" name="Int. J. Cancer" volume="63" first="544" last="550">
<title>Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding.</title>
<authorList>
<person name="Peterziel H."/>
<person name="Culig Z."/>
<person name="Stober J."/>
<person name="Hobisch A."/>
<person name="Radmayr C."/>
<person name="Bartsch G."/>
<person name="Klocker H."/>
<person name="Cato A.C.B."/>
</authorList>
<dbReference type="PubMed" id="7591265"/>
<dbReference type="DOI" id="10.1002/ijc.2910630415"/>
</citation>
<scope>VARIANT PROSTATE CANCER MET-730</scope>
</reference>
<reference key="134">
<citation type="journal article" date="1995" name="J. Clin. Endocrinol. Metab." volume="80" first="2697" last="2699">
<title>Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias.</title>
<authorList>
<person name="Allera A."/>
<person name="Herbst M.A."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="Schweikert H.-U."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="7673412"/>
<dbReference type="DOI" id="10.1210/jc.80.9.2697"/>
</citation>
<scope>VARIANT VAL-568</scope>
</reference>
<reference key="135">
<citation type="journal article" date="1995" name="J. Clin. Endocrinol. Metab." volume="80" first="3494" last="3500">
<title>Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol.</title>
<authorList>
<person name="Elo J.P."/>
<person name="Kvist L."/>
<person name="Leinonen K."/>
<person name="Isomaa V."/>
<person name="Henttu P."/>
<person name="Lukkarinen O."/>
<person name="Vihko P."/>
</authorList>
<dbReference type="PubMed" id="8530589"/>
<dbReference type="DOI" id="10.1210/jc.80.12.3494"/>
</citation>
<scope>VARIANT PROSTATE CANCER LEU-726</scope>
</reference>
<reference key="136">
<citation type="journal article" date="1995" name="Mol. Cell. Endocrinol." volume="111" first="93" last="98">
<title>A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome.</title>
<authorList>
<person name="Gast A."/>
<person name="Neuschmid-Kaspar F."/>
<person name="Klocker H."/>
<person name="Cato A.C.B."/>
</authorList>
<dbReference type="PubMed" id="7649358"/>
<dbReference type="DOI" id="10.1016/0303-7207(95)03554-K"/>
</citation>
<scope>VARIANT PAIS THR-596</scope>
</reference>
<reference key="137">
<citation type="journal article" date="1995" name="N. Engl. J. Med." volume="332" first="1393" last="1398">
<title>Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.</title>
<authorList>
<person name="Taplin M.-E."/>
<person name="Bubley G.J."/>
<person name="Shuster T.D."/>
<person name="Frantz M.E."/>
<person name="Spooner A.E."/>
<person name="Ogata G.K."/>
<person name="Keer H.N."/>
<person name="Balk S.P."/>
</authorList>
<dbReference type="PubMed" id="7723794"/>
<dbReference type="DOI" id="10.1056/NEJM199505253322101"/>
</citation>
<scope>VARIANTS PROSTATE CANCER</scope>
</reference>
<reference key="138">
<citation type="journal article" date="1996" name="Am. J. Med. Genet." volume="63" first="218" last="222">
<title>The clinical and molecular spectrum of androgen insensitivity syndromes.</title>
<authorList>
<person name="Hiort O."/>
<person name="Sinnecker G.H."/>
<person name="Holterhus P.M."/>
<person name="Nitsche E.M."/>
<person name="Kruse K."/>
</authorList>
<dbReference type="PubMed" id="8723113"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19960503)63:1&lt;218::AID-AJMG38>3.0.CO;2-P"/>
</citation>
<scope>VARIANTS AIS AND PAIS</scope>
</reference>
<reference key="139">
<citation type="journal article" date="1996" name="Clin. Cancer Res." volume="2" first="277" last="285">
<title>Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.</title>
<authorList>
<person name="Tilley W.D."/>
<person name="Buchanan G."/>
<person name="Hickey T.E."/>
<person name="Bentel J.M."/>
</authorList>
<dbReference type="PubMed" id="9816170"/>
</citation>
<scope>VARIANTS PROSTATE CANCER</scope>
</reference>
<reference key="140">
<citation type="journal article" date="1996" name="Clin. Endocrinol. (Oxf.)" volume="45" first="733" last="739">
<title>Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.</title>
<authorList>
<person name="Weidemann W."/>
<person name="Linck B."/>
<person name="Haupt H."/>
<person name="Mentrup B."/>
<person name="Romalo G."/>
<person name="Stockklauser K."/>
<person name="Brinkmann A.O."/>
<person name="Schweikert H.-U."/>
<person name="Spindler K.D."/>
</authorList>
<dbReference type="PubMed" id="9039340"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.1996.8600869.x"/>
</citation>
<scope>VARIANTS PAIS GLN-607; THR-610; LEU-754; HIS-840; THR-842 AND HIS-855</scope>
<scope>VARIANT AIS MET-866</scope>
</reference>
<reference key="141">
<citation type="journal article" date="1996" name="Clin. Genet." volume="50" first="202" last="205">
<title>Rapid detection of a mutation hot-spot in the human androgen receptor.</title>
<authorList>
<person name="Malmgren H."/>
<person name="Gustavsson J."/>
<person name="Tuvemo T."/>
<person name="Dahl N."/>
</authorList>
<dbReference type="PubMed" id="9001799"/>
</citation>
<scope>VARIANT AIS CYS-855</scope>
</reference>
<reference key="142">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="265" last="273">
<title>Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Bevan C.L."/>
<person name="Brown B.B."/>
<person name="Davies H.R."/>
<person name="Evans B.A.J."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="8824883"/>
<dbReference type="DOI" id="10.1093/hmg/5.2.265"/>
</citation>
<scope>VARIANTS PAIS ILE-742; ILE-780; GLU-798; CYS-840; HIS-855 AND MET-869</scope>
</reference>
<reference key="143">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="236" last="243">
<title>Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.</title>
<authorList>
<person name="Choong C.S."/>
<person name="Sturm M.J."/>
<person name="Strophair J.A."/>
<person name="McCulloch R.K."/>
<person name="Tilley W.D."/>
<person name="Leedman P.J."/>
<person name="Hurley D.M."/>
</authorList>
<dbReference type="PubMed" id="8550758"/>
<dbReference type="DOI" id="10.1210/jcem.81.1.8550758"/>
</citation>
<scope>VARIANT PAIS ARG-909</scope>
</reference>
<reference key="144">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="1984" last="1988">
<title>A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.</title>
<authorList>
<person name="Lumbroso S."/>
<person name="Lobaccaro J.-M."/>
<person name="Georget V."/>
<person name="Leger J."/>
<person name="Poujol N."/>
<person name="Terouanne B."/>
<person name="Evain-Brion D."/>
<person name="Czernichow P."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8626869"/>
<dbReference type="DOI" id="10.1210/jcem.81.5.8626869"/>
</citation>
<scope>VARIANT AIS ARG-707</scope>
</reference>
<reference key="145">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="2994" last="2998">
<title>Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene.</title>
<authorList>
<person name="Rodien P."/>
<person name="Mebarki F."/>
<person name="Mowszowicz I."/>
<person name="Chaussain J.L."/>
<person name="Young J."/>
<person name="Morel Y."/>
<person name="Schaison G."/>
</authorList>
<dbReference type="PubMed" id="8768864"/>
<dbReference type="DOI" id="10.1210/jc.81.8.2994"/>
</citation>
<scope>VARIANT AIS ILE-780</scope>
</reference>
<reference key="146">
<citation type="journal article" date="1996" name="J. Clin. Invest." volume="98" first="1423" last="1431">
<title>A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.</title>
<authorList>
<person name="Choong C.S."/>
<person name="Quigley C.A."/>
<person name="French F.S."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="8823308"/>
<dbReference type="DOI" id="10.1172/JCI118930"/>
</citation>
<scope>VARIANT PAIS LYS-2</scope>
</reference>
<reference key="147">
<citation type="journal article" date="1996" name="J. Steroid Biochem. Mol. Biol." volume="58" first="569" last="575">
<title>Molecular basis of androgen insensitivity.</title>
<authorList>
<person name="Bruggenwirth H.T."/>
<person name="Boehmer A.L.M."/>
<person name="Verleun-Mooijman M.C.T."/>
<person name="Hoogenboezem T."/>
<person name="Kleijer W.J."/>
<person name="Otten B.J."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="8918984"/>
<dbReference type="DOI" id="10.1016/0960-0760(96)00095-7"/>
</citation>
<scope>VARIANT AIS ASP-573</scope>
</reference>
<reference key="148">
<citation type="journal article" date="1996" name="J. Urol." volume="156" first="828" last="831">
<title>Androgen receptor gene mutations are rarely associated with isolated penile hypospadias.</title>
<authorList>
<person name="Sutherland R.W."/>
<person name="Wiener J.S."/>
<person name="Hicks J.P."/>
<person name="Marcelli M."/>
<person name="Gonzales E.T. Jr."/>
<person name="Roth D.R."/>
<person name="Lamb D.J."/>
</authorList>
<dbReference type="PubMed" id="8683794"/>
<dbReference type="DOI" id="10.1097/00005392-199608001-00077"/>
</citation>
<scope>VARIANT AIS SER-548</scope>
</reference>
<reference key="149">
<citation type="journal article" date="1996" name="Mol. Cell. Endocrinol." volume="116" first="137" last="147">
<title>Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Poujol N."/>
<person name="Chiche L."/>
<person name="Lumbroso S."/>
<person name="Brown T.R."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8647313"/>
<dbReference type="DOI" id="10.1016/0303-7207(95)03709-8"/>
</citation>
<scope>VARIANT AIS PRO-616</scope>
</reference>
<reference key="150">
<citation type="journal article" date="1996" name="Mol. Cell. Endocrinol." volume="120" first="15" last="24">
<title>Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor.</title>
<authorList>
<person name="Imasaki K."/>
<person name="Okabe T."/>
<person name="Murakami H."/>
<person name="Tanaka Y."/>
<person name="Haji M."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8809734"/>
<dbReference type="DOI" id="10.1016/0303-7207(96)03812-9"/>
</citation>
<scope>VARIANT AIS PHE-579</scope>
<scope>VARIANT PAIS TYR-582</scope>
</reference>
<reference key="151">
<citation type="journal article" date="1996" name="Prostate" volume="28" first="162" last="171">
<title>Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis.</title>
<authorList>
<person name="Evans B.A.J."/>
<person name="Harper M.E."/>
<person name="Daniells C.E."/>
<person name="Watts C.E."/>
<person name="Matenhelia S."/>
<person name="Green J."/>
<person name="Griffiths K."/>
</authorList>
<dbReference type="PubMed" id="8628719"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0045(199603)28:3&lt;162::AID-PROS3>3.0.CO;2-H"/>
</citation>
<scope>VARIANT PROSTATE CANCER GLU-798</scope>
</reference>
<reference key="152">
<citation type="journal article" date="1996" name="Prostate" volume="29" first="153" last="158">
<title>Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Akakura K."/>
<person name="Komiya A."/>
<person name="Aida S."/>
<person name="Akimoto S."/>
<person name="Shimazaki J."/>
</authorList>
<dbReference type="PubMed" id="8827083"/>
<dbReference type="DOI" id="10.1002/1097-0045(199609)29:3&lt;153::AID-PROS2990290303>3.0.CO;2-5"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-877</scope>
</reference>
<reference key="153">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="60" first="1003" last="1006">
<title>Germ-line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling.</title>
<authorList>
<person name="Boehmer A.L.M."/>
<person name="Brinkmann A.O."/>
<person name="Niermeijer M.F."/>
<person name="Bakker L."/>
<person name="Halley D.J.J."/>
<person name="Drop S.L.S."/>
</authorList>
<dbReference type="PubMed" id="9106550"/>
</citation>
<scope>VARIANT AIS HIS-855</scope>
</reference>
<reference key="154">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="314" last="319">
<title>Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.</title>
<authorList>
<person name="Koivisto P."/>
<person name="Kononen J."/>
<person name="Palmberg C."/>
<person name="Tammela T."/>
<person name="Hyytinen E."/>
<person name="Isola J."/>
<person name="Trapman J."/>
<person name="Cleutjens K."/>
<person name="Noordzij A."/>
<person name="Visakorpi T."/>
<person name="Kallioniemi O.-P."/>
</authorList>
<dbReference type="PubMed" id="9000575"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-683</scope>
</reference>
<reference key="155">
<citation type="journal article" date="1997" name="Clin. Endocrinol. (Oxf.)" volume="46" first="497" last="506">
<title>Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Tincello D.G."/>
<person name="Saunders P.T."/>
<person name="Hodgins M.B."/>
<person name="Simpson N.B."/>
<person name="Edwards C.R."/>
<person name="Hargreaves T.B."/>
<person name="Wu F.C."/>
</authorList>
<dbReference type="PubMed" id="9196614"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.1997.1140927.x"/>
</citation>
<scope>VARIANTS PAIS LYS-608 AND GLY-772</scope>
</reference>
<reference key="156">
<citation type="journal article" date="1997" name="Dis. Markers" volume="13" first="99" last="105">
<title>Molecular analysis of androgen resistance syndromes in Egyptian patients.</title>
<authorList>
<person name="Essawi M."/>
<person name="Gad Y.Z."/>
<person name="el-Rouby O."/>
<person name="Temtamy S.A."/>
<person name="Sabour Y.A."/>
<person name="el-Awady M.K."/>
</authorList>
<dbReference type="PubMed" id="9160185"/>
</citation>
<scope>VARIANT AIS MET-889</scope>
</reference>
<reference key="157">
<citation type="journal article" date="1997" name="Eur. J. Pediatr." volume="156" first="7" last="14">
<title>Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene.</title>
<authorList>
<person name="Sinnecker G.H."/>
<person name="Hiort O."/>
<person name="Nitsche E.M."/>
<person name="Holterhus P.M."/>
<person name="Kruse K."/>
</authorList>
<dbReference type="PubMed" id="9007482"/>
<dbReference type="DOI" id="10.1007/s004310050542"/>
</citation>
<scope>VARIANT AIS TRP-779</scope>
</reference>
<reference key="158">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="9" first="57" last="61">
<title>Mutations of the androgen receptor gene in patients with complete androgen insensitivity.</title>
<authorList>
<person name="Jakubiczka S."/>
<person name="Nedel S."/>
<person name="Werder E.A."/>
<person name="Schleiermacher E."/>
<person name="Theile U."/>
<person name="Wolff G."/>
<person name="Wieacker P."/>
</authorList>
<dbReference type="PubMed" id="8990010"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)9:1&lt;57::AID-HUMU10>3.3.CO;2-0"/>
</citation>
<scope>VARIANTS AIS VAL-749; CYS-774; ILE-780 AND SER-794</scope>
</reference>
<reference key="159">
<citation type="journal article" date="1997" name="Jpn. J. Clin. Oncol." volume="27" first="389" last="393">
<title>Genetic alterations of androgen receptor gene in Japanese human prostate cancer.</title>
<authorList>
<person name="Watanabe M."/>
<person name="Ushijima T."/>
<person name="Shiraishi T."/>
<person name="Yatani R."/>
<person name="Shimazaki J."/>
<person name="Kotake T."/>
<person name="Sugimura T."/>
<person name="Nagao M."/>
</authorList>
<dbReference type="PubMed" id="9438000"/>
<dbReference type="DOI" id="10.1093/jjco/27.6.389"/>
</citation>
<scope>VARIANTS PROSTATE CANCER IN POLY-GLN REGION; HIS-701 AND ARG-910</scope>
</reference>
<reference key="160">
<citation type="journal article" date="1997" name="Nihon Hinyokika Gakkai Zasshi" volume="88" first="550" last="556">
<title>Androgen receptor gene mutations in prostate cancer.</title>
<authorList>
<person name="Wang C."/>
<person name="Uchida T."/>
</authorList>
<dbReference type="PubMed" id="9184448"/>
</citation>
<scope>VARIANT PROSTATE CANCER GLN-629</scope>
</reference>
<reference key="161">
<citation type="journal article" date="1997" name="J. Obstet. Gynaecol. Res." volume="23" first="277" last="281">
<title>DNA analysis of the androgen receptor gene in two cases with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Komori S."/>
<person name="Sakata K."/>
<person name="Tanaka H."/>
<person name="Shima H."/>
<person name="Koyama K."/>
</authorList>
<dbReference type="PubMed" id="9255042"/>
<dbReference type="DOI" id="10.1111/j.1447-0756.1997.tb00845.x"/>
</citation>
<scope>VARIANTS AIS ARG-194 AND CYS-855</scope>
</reference>
<reference key="162">
<citation type="journal article" date="1997" name="J. Pediatr." volume="131" first="386" last="392">
<title>Etiologic classification of severe hypospadias: implications for prognosis and management.</title>
<authorList>
<person name="Albers N."/>
<person name="Ulrichs C."/>
<person name="Gluer S."/>
<person name="Hiort O."/>
<person name="Sinnecker G.H."/>
<person name="Mildenberger H."/>
<person name="Brodehl J."/>
</authorList>
<dbReference type="PubMed" id="9329414"/>
</citation>
<scope>VARIANTS PAIS ALA-708 AND GLY-870</scope>
</reference>
<reference key="163">
<citation type="journal article" date="1997" name="J. Reprod. Med." volume="42" first="424" last="428">
<title>Complete androgen insensitivity syndrome. Molecular characterization in two Chinese women.</title>
<authorList>
<person name="Ko T.M."/>
<person name="Yang Y.S."/>
<person name="Wu M.Y."/>
<person name="Kao C.H."/>
<person name="Hsu P.M."/>
<person name="Chuang S.M."/>
<person name="Lee T.Y."/>
</authorList>
<dbReference type="PubMed" id="9252933"/>
</citation>
<scope>VARIANTS AIS ASN-732 AND THR-765</scope>
</reference>
<reference key="164">
<citation type="journal article" date="1997" name="J. Steroid Biochem. Mol. Biol." volume="61" first="19" last="26">
<title>Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Bevan C.L."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="9328206"/>
<dbReference type="DOI" id="10.1016/S0960-0760(97)00001-0"/>
</citation>
<scope>VARIANTS AIS ASP-750; PHE-762; THR-765; ASN-864 AND PHE-907</scope>
</reference>
<reference key="165">
<citation type="journal article" date="1997" name="J. Urol." volume="158" first="1553" last="1556">
<title>Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Radmayr C."/>
<person name="Culig Z."/>
<person name="Glatzl J."/>
<person name="Neuschmid-Kaspar F."/>
<person name="Bartsch G."/>
<person name="Klocker H."/>
</authorList>
<dbReference type="PubMed" id="9302173"/>
<dbReference type="DOI" id="10.1097/00005392-199710000-00075"/>
</citation>
<scope>VARIANT PAIS GLY-703</scope>
<scope>VARIANT AIS LEU-916</scope>
</reference>
<reference key="166">
<citation type="journal article" date="1998" name="Arch. Gynecol. Obstet." volume="261" first="95" last="100">
<title>Molecular analysis of the androgen receptor gene in 4 patients with complete androgen insensitivity.</title>
<authorList>
<person name="Komori S."/>
<person name="Kasumi H."/>
<person name="Sakata K."/>
<person name="Tanaka H."/>
<person name="Hamada K."/>
<person name="Koyama K."/>
</authorList>
<dbReference type="PubMed" id="9544375"/>
<dbReference type="DOI" id="10.1007/s004040050206"/>
</citation>
<scope>VARIANTS AIS CYS-571; GLN-752 AND CYS-774</scope>
</reference>
<reference key="167">
<citation type="journal article" date="1998" name="Braz. J. Med. Biol. Res." volume="31" first="775" last="778">
<title>Mutations of androgen receptor gene in Brazilian patients with male pseudohermaphroditism.</title>
<authorList>
<person name="Cabral D.F."/>
<person name="Maciel-Guerra A.T."/>
<person name="Hackel C."/>
</authorList>
<dbReference type="PubMed" id="9698822"/>
<dbReference type="DOI" id="10.1590/S0100-879X1998000600008"/>
</citation>
<scope>VARIANTS AIS HIS-615 AND GLN-752</scope>
</reference>
<reference key="168">
<citation type="journal article" date="1998" name="Clin. Genet." volume="54" first="185" last="192">
<title>Analysis of the transactivation domain of the androgen receptor in patients with male infertility.</title>
<authorList>
<person name="Wang Q."/>
<person name="Ghadessy F.J."/>
<person name="Yong E.L."/>
</authorList>
<dbReference type="PubMed" id="9788719"/>
</citation>
<scope>VARIANT AIS ARG-214</scope>
</reference>
<reference key="169">
<citation type="journal article" date="1998" name="Gynecol. Endocrinol." volume="12" first="75" last="82">
<title>One additional mutation at exon A amplifies thermolability of androgen receptor in a case with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Tanaka H."/>
<person name="Komori S."/>
<person name="Sakata K."/>
<person name="Shima H."/>
<person name="Koyama K."/>
</authorList>
<dbReference type="PubMed" id="9610419"/>
</citation>
<scope>VARIANTS AIS PRO-255 AND ALA-820</scope>
</reference>
<reference key="170">
<citation type="journal article" date="1998" name="Hum. Genet." volume="103" first="529" last="531">
<title>Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Lundberg Giwercman Y."/>
<person name="Nikoshkov A."/>
<person name="Lindsten K."/>
<person name="Bystroem B."/>
<person name="Pousette A."/>
<person name="Chibalin A.V."/>
<person name="Arvidsson S."/>
<person name="Tiulpakov A."/>
<person name="Semitcheva T.V."/>
<person name="Peterkova V."/>
<person name="Hagenfeldt K."/>
<person name="Ritzen E.M."/>
<person name="Wedell A."/>
</authorList>
<dbReference type="PubMed" id="9856504"/>
<dbReference type="DOI" id="10.1007/s004390050864"/>
</citation>
<scope>VARIANTS AIS THR-765; TYR-784 AND THR-895</scope>
<scope>VARIANT PAIS GLY-840</scope>
</reference>
<reference key="171">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="337" last="339">
<title>A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Doerk T."/>
<person name="Schnieders F."/>
<person name="Jakubiczka S."/>
<person name="Wieacker P."/>
<person name="Schroeder-Kurth T."/>
<person name="Schmidtke J."/>
</authorList>
<dbReference type="PubMed" id="9554754"/>
</citation>
<scope>VARIANT AIS VAL-695</scope>
</reference>
<reference key="172">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="339" last="339">
<title>An androgen receptor gene mutation (A645D) in a boy with a normal phenotype.</title>
<authorList>
<person name="Nordenskjoeld A."/>
<person name="Soederhaell S."/>
</authorList>
<dbReference type="PubMed" id="9554755"/>
</citation>
<scope>VARIANT ASP-645</scope>
</reference>
<reference key="173">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="12" first="220" last="220">
<title>Single amino acid substitution in the hormone-binding domain of the androgen receptor in a family with complete androgen insensitivity syndrome (CAIS).</title>
<authorList>
<person name="Knoke I."/>
<person name="Jakubiczka S."/>
<person name="Rohrer T."/>
<person name="Hanimann B."/>
<person name="Werder E.A."/>
<person name="Wieacker P."/>
</authorList>
</citation>
<scope>VARIANT AIS LEU-892</scope>
</reference>
<reference key="174">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="1173" last="1176">
<title>Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor.</title>
<authorList>
<person name="Weidemann W."/>
<person name="Peters B."/>
<person name="Romalo G."/>
<person name="Spindler K.D."/>
<person name="Schweikert H.-U."/>
</authorList>
<dbReference type="PubMed" id="9543136"/>
<dbReference type="DOI" id="10.1210/jc.83.4.1173"/>
</citation>
<scope>VARIANT PAIS GLN-607</scope>
</reference>
<reference key="175">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="3597" last="3603">
<title>Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Georget V."/>
<person name="Terouanne B."/>
<person name="Lumbroso S."/>
<person name="Nicolas J.C."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="9768671"/>
<dbReference type="DOI" id="10.1210/jc.83.10.3597"/>
</citation>
<scope>VARIANTS PAIS VAL-743 AND CYS-840</scope>
</reference>
<reference key="176">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="4303" last="4309">
<title>Azoospermia associated with a mutation in the ligand-binding domain of an androgen receptor displaying normal ligand binding, but defective trans-activation.</title>
<authorList>
<person name="Wang Q."/>
<person name="Ghadessy F.J."/>
<person name="Trounson A."/>
<person name="de Kretser D."/>
<person name="McLachlan R."/>
<person name="Ng S.C."/>
<person name="Yong E.L."/>
</authorList>
<dbReference type="PubMed" id="9851768"/>
<dbReference type="DOI" id="10.1210/jc.83.12.4303"/>
</citation>
<scope>VARIANT AIS GLU-798</scope>
</reference>
<reference key="177">
<citation type="journal article" date="1998" name="J. Pediatr." volume="132" first="939" last="943">
<title>Inherited and de novo androgen receptor gene mutations: investigation of single-case families.</title>
<authorList>
<person name="Hiort O."/>
<person name="Sinnecker G.H."/>
<person name="Holterhus P.M."/>
<person name="Nitsche E.M."/>
<person name="Kruse K."/>
</authorList>
<dbReference type="PubMed" id="9627582"/>
<dbReference type="DOI" id="10.1016/S0022-3476(98)70387-7"/>
</citation>
<scope>VARIANTS AIS</scope>
</reference>
<reference key="178">
<citation type="journal article" date="1998" name="Mol. Cell. Endocrinol." volume="137" first="41" last="50">
<title>Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.</title>
<authorList>
<person name="Yong E.L."/>
<person name="Tut T.G."/>
<person name="Ghadessy F.J."/>
<person name="Prins G."/>
<person name="Ratnam S.S."/>
</authorList>
<dbReference type="PubMed" id="9607727"/>
<dbReference type="DOI" id="10.1016/S0303-7207(97)00229-3"/>
</citation>
<scope>VARIANT PAIS THR-758</scope>
</reference>
<reference key="179">
<citation type="journal article" date="1999" name="Andrologia" volume="31" first="199" last="201">
<title>A new point mutation of the androgen receptor gene in a patient with partial androgen resistance and severe oligozoospermia.</title>
<authorList>
<person name="Knoke I."/>
<person name="Jakubiczka S."/>
<person name="Lehnert H."/>
<person name="Wieacker P."/>
</authorList>
<dbReference type="PubMed" id="10470409"/>
<dbReference type="DOI" id="10.1046/j.1439-0272.1999.00278.x"/>
</citation>
<scope>VARIANT PAIS LEU-911</scope>
</reference>
<reference key="180">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="2511" last="2515">
<title>Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.</title>
<authorList>
<person name="Taplin M.-E."/>
<person name="Bubley G.J."/>
<person name="Ko Y.J."/>
<person name="Small E.J."/>
<person name="Upton M."/>
<person name="Rajeshkumar B."/>
<person name="Balk S.P."/>
</authorList>
<dbReference type="PubMed" id="10363963"/>
</citation>
<scope>VARIANTS PROSTATE CANCER ALA-877 AND ASN-890</scope>
</reference>
<reference key="181">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="353" last="353">
<title>A novel point mutation (R840S) in the androgen receptor in a Brazilian family with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Melo K.F.S."/>
<person name="Latronico A.C."/>
<person name="Costa E.M.F."/>
<person name="Billerbeck A.E.C."/>
<person name="Mendonca B.B."/>
<person name="Arnhold I.J.P."/>
</authorList>
<dbReference type="PubMed" id="10502786"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(199910)14:4&lt;353::AID-HUMU16>3.0.CO;2-7"/>
</citation>
<scope>VARIANT PAIS SER-840</scope>
</reference>
<reference key="182">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="527" last="539">
<title>Analysis of exon 1 mutations in the androgen receptor gene.</title>
<authorList>
<person name="Gottlieb B."/>
<person name="Vasiliou D.M."/>
<person name="Lumbroso R."/>
<person name="Beitel L.K."/>
<person name="Pinsky L."/>
<person name="Trifiro M.A."/>
</authorList>
<dbReference type="PubMed" id="10571951"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(199912)14:6&lt;527::AID-HUMU12>3.0.CO;2-X"/>
</citation>
<scope>VARIANTS AIS ARG-390 AND ARG-443</scope>
</reference>
<reference key="183">
<citation type="journal article" date="1999" name="Hum. Reprod." volume="14" first="664" last="670">
<title>Androgen receptor gene mutations in 46,XY females with germ cell tumours.</title>
<authorList>
<person name="Chen C.P."/>
<person name="Chern S.R."/>
<person name="Wang T.Y."/>
<person name="Wang W."/>
<person name="Wang K.L."/>
<person name="Jeng C.J."/>
</authorList>
<dbReference type="PubMed" id="10221692"/>
<dbReference type="DOI" id="10.1093/humrep/14.3.664"/>
</citation>
<scope>VARIANT PAIS GLN-607</scope>
<scope>VARIANT AIS LYS-681</scope>
</reference>
<reference key="184">
<citation type="journal article" date="1999" name="Int. J. Urol." volume="6" first="327" last="330">
<title>A case of complete testicular feminization: laparoscopic orchiectomy and analysis of androgen receptor gene mutation.</title>
<authorList>
<person name="Kanayama H."/>
<person name="Naroda T."/>
<person name="Inoue Y."/>
<person name="Kurokawa Y."/>
<person name="Kagawa S."/>
</authorList>
<dbReference type="PubMed" id="10404311"/>
<dbReference type="DOI" id="10.1046/j.1442-2042.1999.00065.x"/>
</citation>
<scope>VARIANT AIS LEU-892</scope>
</reference>
<reference key="185">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="805" last="810">
<title>Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.</title>
<authorList>
<person name="Shkolny D.L."/>
<person name="Beitel L.K."/>
<person name="Ginsberg J."/>
<person name="Pekeles G."/>
<person name="Arbour L."/>
<person name="Pinsky L."/>
<person name="Trifiro M.A."/>
</authorList>
<dbReference type="PubMed" id="10022458"/>
<dbReference type="DOI" id="10.1210/jc.84.2.805"/>
</citation>
<scope>VARIANT PAIS ALA-772</scope>
<scope>VARIANT AIS GLY-871</scope>
</reference>
<reference key="186">
<citation type="journal article" date="1999" name="J. Pathol." volume="189" first="559" last="563">
<title>Androgen receptor gene mutations in hormone-refractory prostate cancer.</title>
<authorList>
<person name="Wallen M.J."/>
<person name="Linja M."/>
<person name="Kaartinen K."/>
<person name="Schleutker J."/>
<person name="Visakorpi T."/>
</authorList>
<dbReference type="PubMed" id="10629558"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-9896(199912)189:4&lt;559::AID-PATH471>3.0.CO;2-Y"/>
</citation>
<scope>VARIANTS PROSTATE CANCER IN POLY-GLN REGION AND ALA-683</scope>
</reference>
<reference key="187">
<citation type="journal article" date="1999" name="J. Urol." volume="162" first="2192" last="2199">
<title>Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.</title>
<authorList>
<person name="Zhao X.Y."/>
<person name="Boyle B."/>
<person name="Krishnan A.V."/>
<person name="Navone N.M."/>
<person name="Peehl D.M."/>
<person name="Feldman D."/>
</authorList>
<dbReference type="PubMed" id="10569618"/>
<dbReference type="DOI" id="10.1016/S0022-5347(05)68158-X"/>
</citation>
<scope>VARIANTS PROSTATE CANCER HIS-701 AND ALA-877</scope>
</reference>
<reference key="188">
<citation type="journal article" date="1999" name="Lancet" volume="354" first="1444" last="1445">
<title>Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation.</title>
<authorList>
<person name="Ong Y.C."/>
<person name="Wong H.B."/>
<person name="Adaikan G."/>
<person name="Yong E.L."/>
</authorList>
<dbReference type="PubMed" id="10543676"/>
<dbReference type="DOI" id="10.1016/S0140-6736(99)03205-5"/>
</citation>
<scope>VARIANT PAIS THR-807</scope>
</reference>
<reference key="189">
<citation type="journal article" date="1999" name="Mol. Cell. Endocrinol." volume="148" first="47" last="53">
<title>An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.</title>
<authorList>
<person name="Peters I."/>
<person name="Weidemann W."/>
<person name="Romalo G."/>
<person name="Knorr D."/>
<person name="Schweikert H.-U."/>
<person name="Spindler K.D."/>
</authorList>
<dbReference type="PubMed" id="10221770"/>
<dbReference type="DOI" id="10.1016/S0303-7207(98)00237-8"/>
</citation>
<scope>VARIANT AIS LEU-892</scope>
</reference>
<reference key="190">
<citation type="journal article" date="1999" name="Mol. Endocrinol." volume="13" first="2065" last="2075">
<title>A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1.</title>
<authorList>
<person name="Nazareth L.V."/>
<person name="Stenoien D.L."/>
<person name="Bingman W.E. III"/>
<person name="James A.J."/>
<person name="Wu C."/>
<person name="Zhang Y."/>
<person name="Edwards D.P."/>
<person name="Mancini M."/>
<person name="Marcelli M."/>
<person name="Lamb D.J."/>
<person name="Weigel N.L."/>
</authorList>
<dbReference type="PubMed" id="10598582"/>
<dbReference type="DOI" id="10.1210/me.13.12.2065"/>
</citation>
<scope>VARIANT PROSTATE CANCER TYR-619</scope>
</reference>
<reference key="191">
<citation type="journal article" date="2000" name="Mol. Endocrinol." volume="14" first="544" last="544">
<authorList>
<person name="Nazareth L.V."/>
<person name="Stenoien D.L."/>
<person name="Bingman W.E. III"/>
<person name="James A.J."/>
<person name="Wu C."/>
<person name="Zhang Y."/>
<person name="Edwards D.P."/>
<person name="Mancini M."/>
<person name="Marcelli M."/>
<person name="Lamb D.J."/>
<person name="Weigel N.L."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="192">
<citation type="journal article" date="1999" name="Pediatr. Res." volume="46" first="684" last="690">
<title>Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome.</title>
<authorList>
<person name="Holterhus P.M."/>
<person name="Wiebel J."/>
<person name="Sinnecker G.H."/>
<person name="Bruggenwirth H.T."/>
<person name="Sippell W.G."/>
<person name="Brinkmann A.O."/>
<person name="Kruse K."/>
<person name="Hiort O."/>
</authorList>
<dbReference type="PubMed" id="10590024"/>
<dbReference type="DOI" id="10.1203/00006450-199912000-00008"/>
</citation>
<scope>VARIANT AIS THR-596</scope>
</reference>
<reference key="193">
<citation type="journal article" date="1999" name="Tohoku J. Exp. Med." volume="187" first="263" last="272">
<title>Point mutations in the steroid-binding domain of the androgen receptor gene of five Japanese patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Yaegashi N."/>
<person name="Uehara S."/>
<person name="Senoo M."/>
<person name="Sato J."/>
<person name="Fujiwara J."/>
<person name="Funato T."/>
<person name="Sasaki T."/>
<person name="Yajima A."/>
</authorList>
<dbReference type="PubMed" id="10458483"/>
<dbReference type="DOI" id="10.1620/tjem.187.263"/>
</citation>
<scope>VARIANTS AIS PHE-812 AND GLN-831</scope>
</reference>
<reference key="194">
<citation type="journal article" date="1999" name="Urol. Res." volume="27" first="49" last="55">
<title>Screening for mutations in candidate genes for hypospadias.</title>
<authorList>
<person name="Nordenskjoeld A."/>
<person name="Friedman E."/>
<person name="Tapper-Persson M."/>
<person name="Soederhaell C."/>
<person name="Leviav A."/>
<person name="Svensson J."/>
<person name="Anvret M."/>
</authorList>
<dbReference type="PubMed" id="10092153"/>
<dbReference type="DOI" id="10.1007/s002400050088"/>
</citation>
<scope>VARIANTS THR-597 AND LEU-725</scope>
</reference>
<reference key="195">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="944" last="949">
<title>Androgen receptor mutations in prostate cancer.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Ittmann M."/>
<person name="Mariani S."/>
<person name="Sutherland R.W."/>
<person name="Nigam R."/>
<person name="Murthy L."/>
<person name="Zhao Y."/>
<person name="DiConcini D."/>
<person name="Puxeddu E."/>
<person name="Esen A."/>
<person name="Eastham J."/>
<person name="Weigel N.L."/>
<person name="Lamb D.J."/>
</authorList>
<dbReference type="PubMed" id="10706109"/>
</citation>
<scope>VARIANTS PROSTATE CANCER ALA-575; ARG-580; VAL-586; TYR-619; ALA-757 AND GLY-846</scope>
</reference>
<reference key="196">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="658" last="665">
<title>Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.</title>
<authorList>
<person name="Ahmed S.F."/>
<person name="Cheng A."/>
<person name="Dovey L."/>
<person name="Hawkins J.R."/>
<person name="Martin H."/>
<person name="Rowland J."/>
<person name="Shimura N."/>
<person name="Tait A.D."/>
<person name="Hughes I.A."/>
</authorList>
<dbReference type="PubMed" id="10690872"/>
<dbReference type="DOI" id="10.1210/jc.85.2.658"/>
</citation>
<scope>VARIANTS AIS AND PAIS</scope>
</reference>
<reference key="197">
<citation type="journal article" date="2001" name="J. Hum. Genet." volume="46" first="560" last="565">
<title>Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Chavez B."/>
<person name="Mendez J.P."/>
<person name="Ulloa-Aguirre A."/>
<person name="Larrea F."/>
<person name="Vilchis F."/>
</authorList>
<dbReference type="PubMed" id="11587068"/>
<dbReference type="DOI" id="10.1007/s100380170021"/>
</citation>
<scope>VARIANTS PAIS THR-682 AND GLU-711</scope>
<scope>VARIANTS AIS GLU-743; VAL-827; ARG-874 AND TYR-879</scope>
</reference>
<reference key="198">
<citation type="journal article" date="2001" name="J. Invest. Dermatol." volume="116" first="452" last="455">
<title>Polymorphism of the androgen receptor gene is associated with male pattern baldness.</title>
<authorList>
<person name="Ellis J.A."/>
<person name="Stebbing M."/>
<person name="Harrap S.B."/>
</authorList>
<dbReference type="PubMed" id="11231320"/>
<dbReference type="DOI" id="10.1046/j.1523-1747.2001.01261.x"/>
</citation>
<scope>INVOLVEMENT IN AGA</scope>
</reference>
<reference key="199">
<citation type="journal article" date="2002" name="Int. J. Mol. Med." volume="9" first="45" last="48">
<title>Characterization of a novel receptor mutation A->T at exon 4 in complete androgen insensitivity syndrome and a carrier sibling via bidirectional polymorphism sequence analysis.</title>
<authorList>
<person name="Sills E.S."/>
<person name="Sholes T.E."/>
<person name="Perloe M."/>
<person name="Kaplan C.R."/>
<person name="Davis J.G."/>
<person name="Tucker M.J."/>
</authorList>
<dbReference type="PubMed" id="11744994"/>
</citation>
<scope>VARIANT AIS TYR-705</scope>
</reference>
<reference key="200">
<citation type="journal article" date="2005" name="Am. J. Hum. Genet." volume="77" first="140" last="148">
<title>Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.</title>
<authorList>
<person name="Hillmer A.M."/>
<person name="Hanneken S."/>
<person name="Ritzmann S."/>
<person name="Becker T."/>
<person name="Freudenberg J."/>
<person name="Brockschmidt F.F."/>
<person name="Flaquer A."/>
<person name="Freudenberg-Hua Y."/>
<person name="Jamra R.A."/>
<person name="Metzen C."/>
<person name="Heyn U."/>
<person name="Schweiger N."/>
<person name="Betz R.C."/>
<person name="Blaumeiser B."/>
<person name="Hampe J."/>
<person name="Schreiber S."/>
<person name="Schulze T.G."/>
<person name="Hennies H.C."/>
<person name="Schumacher J."/>
<person name="Propping P."/>
<person name="Ruzicka T."/>
<person name="Cichon S."/>
<person name="Wienker T.F."/>
<person name="Kruse R."/>
<person name="Noethen M.M."/>
</authorList>
<dbReference type="PubMed" id="15902657"/>
<dbReference type="DOI" id="10.1086/431425"/>
</citation>
<scope>INVOLVEMENT IN AGA</scope>
</reference>
<reference key="201">
<citation type="journal article" date="2005" name="Neurology" volume="64" first="1458" last="1460">
<title>A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophy.</title>
<authorList>
<person name="Echaniz-Laguna A."/>
<person name="Rousso E."/>
<person name="Anheim M."/>
<person name="Cossee M."/>
<person name="Tranchant C."/>
</authorList>
<dbReference type="PubMed" id="15851746"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000158617.41819.F3"/>
</citation>
<scope>INVOLVEMENT IN SMAX1</scope>
</reference>
<reference key="202">
<citation type="journal article" date="2006" name="J. Mol. Endocrinol." volume="36" first="361" last="368">
<title>Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.</title>
<authorList>
<person name="Jaeaeskelaeinen J."/>
<person name="Deeb A."/>
<person name="Schwabe J.W."/>
<person name="Mongan N.P."/>
<person name="Martin H."/>
<person name="Hughes I.A."/>
</authorList>
<dbReference type="PubMed" id="16595706"/>
<dbReference type="DOI" id="10.1677/jme.1.01885"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS AIS ASN-695; CYS-763; HIS-774; GLU-798; HIS-855 AND PHE-907</scope>
</reference>
<comment type="function">
<text evidence="43 47 63 66 68 73 80">Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="78">AIM-100 (4-amino-5,6-biaryl-furo[2,3-d]pyrimidine) suppresses TNK2-mediated phosphorylation at Tyr-267. Inhibits the binding of the Tyr-267 phosphorylated form to androgen-responsive enhancers (AREs) and its transcriptional activity.</text>
</comment>
<comment type="subunit">
<text evidence="4 8 10 11 21 25 29 30 31 32 33 41 43 46 47 52 53 57 59 60 61 62 63 64 66 67 68 69 70 71 73 74 77 80 82 84">Binds DNA as a homodimer. Part of a ternary complex containing AR, EFCAB6/DJBP and PARK7. Interacts with HIPK3 and NR0B2 in the presence of androgen. The ligand binding domain interacts with KAT7/HBO1 in the presence of dihydrotestosterone. Interacts with EFCAB6/DJBP, PELP1, PQBP1, RANBP9, RBAK, SPDEF, SRA1, TGFB1I1, ZNF318 and RREB1. Interacts with ZMIZ1/ZIMP10 and ZMIZ2/ZMIP7 which both enhance its transactivation activity. Interacts with SLC30A9 and RAD54L2/ARIP4. Interacts via the ligand-binding domain with LXXLL and FXXLF motifs from NCOA1, NCOA2, NCOA3, NCOA4 and MAGEA11. The AR N-terminal poly-Gln region binds Ran resulting in enhancement of AR-mediated transactivation. Ran-binding decreases as the poly-Gln length increases. Interacts with HIP1 (via coiled coil domain). Interacts (via ligand-binding domain) with TRIM68. Interacts with TNK2. Interacts with USP26. Interacts with RNF6. Interacts (regulated by RNF6 probably through polyubiquitination) with RNF14; regulates AR transcriptional activity. Interacts with PRMT2 and TRIM24. Interacts with GNB2L1/RACK1. Interacts with RANBP10; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with PRPF6 in a hormone-independent way; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with STK4/MST1. Interacts with ZIPK/DAPK3. Interacts with LPXN. Interacts with MAK. Part of a complex containing AR, MAK and NCOA3. Interacts with CRY1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2623522">
<id>Q8WV28</id>
<label>BLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1047576">
<id>P78543</id>
<label>BTG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-851690">
<id>O89110</id>
<label>Casp8</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2802973">
<id>O14595</id>
<label>CTDSP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1632155">
<id>P20711</id>
<label>DDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79704">
<id>P11308</id>
<label>ERG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1055635">
<id>P07332</id>
<label>FES</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1759806">
<id>O75593</id>
<label>FOXH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1371343">
<id>Q9R1E0</id>
<label>Foxo1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-308629">
<id>P56524</id>
<label>HDAC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2867186">
<id>Q16666</id>
<label>IFI16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1384248">
<id>O15357</id>
<label>INPPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1224969">
<id>Q15652</id>
<label>JMJD1C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-473199">
<id>O95251</id>
<label>KAT7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1220791">
<id>P07288</id>
<label>KLK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3911321">
<id>P20794</id>
<label>MAK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-751664">
<id>P42679</id>
<label>MATK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-81236">
<id>Q15596</id>
<label>NCOA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-78670">
<id>Q14686</id>
<label>NCOA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1164361">
<id>Q99497</id>
<label>PARK7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>37</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-353193">
<id>Q06830</id>
<label>PRDX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2130308">
<id>Q9UBS8</id>
<label>RNF14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2341483">
<id>Q9Y252</id>
<label>RNF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3923013">
<id>O14796</id>
<label>SH2D1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-9453524">
<id>Q6S5L8</id>
<label>SHC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3956977">
<id>Q5VZ18</id>
<label>SHE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-957413">
<id>Q06986</id>
<label>Siah2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1567153">
<id>Q15797</id>
<label>SMAD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3929549">
<id>O14544</id>
<label>SOCS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-6083058">
<id>Q9ULZ2</id>
<label>STAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3389814">
<id>Q9HBL0</id>
<label>TNS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2693298">
<id>O96028</id>
<label>WHSC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of GNB2L1.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P10275-1</id>
<name>1</name>
<name>AR-B</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P10275-2</id>
<name>2</name>
<name>AR-A</name>
<name>Variant AR45</name>
<sequence type="described" ref="VSP_036889 VSP_036890"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="49">Isoform 2 is mainly expressed in heart and skeletal muscle.</text>
</comment>
<comment type="domain">
<text>Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. In the presence of bound steroid the ligand-binding domain interacts with the N-terminal modulating domain, and thereby activates AR transcription factor activity. Agonist binding is required for dimerization and binding to target DNA. The transcription factor activity of the complex formed by ligand-activated AR and DNA is modulated by interactions with coactivator and corepressor proteins. Interaction with RANBP9 is mediated by both the N-terminal domain and the DNA-binding domain. Interaction with EFCAB6/DJBP is mediated by the DNA-binding domain.</text>
</comment>
<comment type="PTM">
<text evidence="26 73 77">Sumoylated on Lys-386 (major) and Lys-520. Ubiquitinated. Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity.</text>
</comment>
<comment type="PTM">
<text evidence="40 58 60 78 80 81 82">Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-534 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression. Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity and may be responsible for androgen-independent progression of prostate cancer. Phosphorylation at Ser-81 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition.</text>
</comment>
<comment type="PTM">
<text evidence="83">Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation.</text>
</comment>
<comment type="polymorphism">
<text>The poly-Gln region of AR is highly polymorphic and the number of Gln varies in the population (from 17 to 26). A smaller size of the poly-Gln region may be associated with the development of prostate cancer.</text>
</comment>
<comment type="polymorphism">
<text>The poly-Gly region of AR is polymorphic and ranges from 24 to 31 Gly. A poly-Gly region shorter or equal to 23 may be associated with the development of androgenetic alopecia.</text>
</comment>
<comment type="disease" evidence="3 6 7 12 13 18 19 23 27 28 35 36 38 39 42 44 45 50 54 65 75 79 86 88 89 91 92 94 98 99 100 101 102 103 105 106 108 111 115 118 120 121 122 125 127 128 129 130 131 135 136 137 139 140 141 142 143 146 147 148 149 153 154 157 158 159 161 162 163 164 166">
<disease id="DI-00116">
<name>Androgen insensitivity syndrome</name>
<acronym>AIS</acronym>
<description>An X-linked recessive form of pseudohermaphroditism due end-organ resistance to androgen. Affected males have female external genitalia, female breast development, blind vagina, absent uterus and female adnexa, and abdominal or inguinal testes, despite a normal 46,XY karyotype.</description>
<dbReference type="MIM" id="300068"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="51">
<disease id="DI-01053">
<name>Spinal and bulbar muscular atrophy X-linked 1</name>
<acronym>SMAX1</acronym>
<description>An X-linked recessive form of spinal muscular atrophy. Spinal muscular atrophy refers to a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. SMAX1 occurs only in men. Age at onset is usually in the third to fifth decade of life, but earlier involvement has been reported. It is characterized by slowly progressive limb and bulbar muscle weakness with fasciculations, muscle atrophy, and gynecomastia. The disorder is clinically similar to classic forms of autosomal spinal muscular atrophy.</description>
<dbReference type="MIM" id="313200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. Caused by trinucleotide CAG repeat expansion. In SMAX1 patients the number of Gln ranges from 38 to 62. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.</text>
</comment>
<comment type="disease">
<text>Defects in AR may play a role in metastatic prostate cancer. The mutated receptor stimulates prostate growth and metastases development despite of androgen ablation. This treatment can reduce primary and metastatic lesions probably by inducing apoptosis of tumor cells when they express the wild-type receptor.</text>
</comment>
<comment type="disease" evidence="3 6 14 15 16 27 34 35 36 37 39 76 89 93 94 96 97 98 100 101 104 107 109 113 117 119 120 122 124 131 132 133 141 145 148 150 152 156 160 163 165">
<disease id="DI-00117">
<name>Androgen insensitivity, partial</name>
<acronym>PAIS</acronym>
<description>A disorder that is characterized by hypospadias, hypogonadism, gynecomastia, genital ambiguity, normal XY karyotype, and a pedigree pattern consistent with X-linked recessive inheritance. Some patients present azoospermia or severe oligospermia without other clinical manifestations.</description>
<dbReference type="MIM" id="312300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>In the absence of ligand, steroid hormone receptors are thought to be weakly associated with nuclear components; hormone binding greatly increases receptor affinity. The hormone-receptor complex appears to recognize discrete DNA sequences upstream of transcriptional start sites.</text>
</comment>
<comment type="miscellaneous">
<text>Transcriptional activity is enhanced by binding to RANBP9.</text>
</comment>
<comment type="miscellaneous">
<text>The level of tyrosine phosphorylation may serve as a diagnostic tool to predict patient outcome in response to hormone-ablation therapy. Inhibition of tyrosine phosphorylation may be an effective intervention target for hormone-refractory prostate cancer.</text>
</comment>
<comment type="similarity">
<text evidence="167">Belongs to the nuclear hormone receptor family. NR3 subfamily.</text>
</comment>
<comment type="similarity">
<text evidence="2">Contains 1 nuclear receptor DNA-binding domain.</text>
</comment>
<comment type="online information" name="Androgen receptor gene mutations database">
<link uri="http://androgendb.mcgill.ca"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ARID685chXq12.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="http://en.wikipedia.org/wiki/Androgen_receptor"/>
<text>Androgen receptor entry</text>
</comment>
<comment type="online information" name="X-chromosome gene database, androgen receptor (AR)">
<link uri="http://www.lovd.nl/AR"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EMBL" id="M20132">
<property type="protein sequence ID" value="AAA51729.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M23263">
<property type="protein sequence ID" value="AAA51775.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M27430">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27423">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27424">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27425">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27426">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27427">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27428">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27429">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34233">
<property type="protein sequence ID" value="AAA51780.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21748">
<property type="protein sequence ID" value="AAA51771.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M35851">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35844">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35845">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35846">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35847">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35848">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35849">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35850">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AX453758">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Unassigned_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049564">
<property type="protein sequence ID" value="CAI43080.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158016">
<property type="protein sequence ID" value="CAI43080.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356358">
<property type="protein sequence ID" value="CAI43080.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158016">
<property type="protein sequence ID" value="CAI40853.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049564">
<property type="protein sequence ID" value="CAI40853.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356358">
<property type="protein sequence ID" value="CAI40853.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356358">
<property type="protein sequence ID" value="CAI40496.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049564">
<property type="protein sequence ID" value="CAI40496.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158016">
<property type="protein sequence ID" value="CAI40496.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471132">
<property type="protein sequence ID" value="EAX05380.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132975">
<property type="protein sequence ID" value="AAI32976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L29496">
<property type="protein sequence ID" value="AAA51770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U16371">
<property type="protein sequence ID" value="AAB60346.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M20260">
<property type="protein sequence ID" value="AAA51774.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S79366">
<property type="protein sequence ID" value="AAB21256.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S79366">
<property type="protein sequence ID" value="AAB21257.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43965.1">
<molecule id="P10275-2"/>
</dbReference>
<dbReference type="PIR" id="A39248">
<property type="entry name" value="A39248"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000035.2">
<property type="nucleotide sequence ID" value="NM_000044.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001011645.1">
<molecule id="P10275-2"/>
<property type="nucleotide sequence ID" value="NM_001011645.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.76704"/>
<dbReference type="PDB" id="1E3G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=657-919"/>
</dbReference>
<dbReference type="PDB" id="1GS4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=670-917"/>
</dbReference>
<dbReference type="PDB" id="1T5Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="1T63">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=669-918"/>
</dbReference>
<dbReference type="PDB" id="1T65">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="1XJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=663-919"/>
</dbReference>
<dbReference type="PDB" id="1XOW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=671-919, B=20-30"/>
</dbReference>
<dbReference type="PDB" id="1XQ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="1Z95">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=672-917"/>
</dbReference>
<dbReference type="PDB" id="2AM9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="A=654-919"/>
</dbReference>
<dbReference type="PDB" id="2AMA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=654-919"/>
</dbReference>
<dbReference type="PDB" id="2AMB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=654-919"/>
</dbReference>
<dbReference type="PDB" id="2AO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="2AX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2AX7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2AX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2AX9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2AXA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2HVC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=669-918"/>
</dbReference>
<dbReference type="PDB" id="2OZ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="2PIO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="L=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="A=669-919"/>
</dbReference>
<dbReference type="PDB" id="2PNU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=654-919"/>
</dbReference>
<dbReference type="PDB" id="2Q7I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=663-919, B=20-30"/>
</dbReference>
<dbReference type="PDB" id="2Q7J">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=663-919"/>
</dbReference>
<dbReference type="PDB" id="2Q7K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=663-919, B=20-30"/>
</dbReference>
<dbReference type="PDB" id="2Q7L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A=663-919"/>
</dbReference>
<dbReference type="PDB" id="2YHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="2YLO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2YLP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2YLQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="2Z4J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=671-918"/>
</dbReference>
<dbReference type="PDB" id="3B5R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3B65">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3B66">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3B67">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3B68">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3BTR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B=621-635"/>
</dbReference>
<dbReference type="PDB" id="3L3X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=670-918"/>
</dbReference>
<dbReference type="PDB" id="3L3Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=670-918"/>
</dbReference>
<dbReference type="PDB" id="3RLJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=671-917"/>
</dbReference>
<dbReference type="PDB" id="3RLL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=671-917"/>
</dbReference>
<dbReference type="PDB" id="3V49">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=654-919, B=21-31"/>
</dbReference>
<dbReference type="PDB" id="3V4A">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=671-919, B=21-31"/>
</dbReference>
<dbReference type="PDB" id="3ZQT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="4HLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=664-919"/>
</dbReference>
<dbReference type="PDB" id="4K7A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.44"/>
<property type="chains" value="A=670-918"/>
</dbReference>
<dbReference type="PDB" id="4OEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OEY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OEZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OFR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OFU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OGH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OH5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OH6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.56"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OHA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.01"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OJ9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.31"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OJB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OK1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OKB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OKT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OKW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="4OLM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDBsum" id="1E3G"/>
<dbReference type="PDBsum" id="1GS4"/>
<dbReference type="PDBsum" id="1T5Z"/>
<dbReference type="PDBsum" id="1T63"/>
<dbReference type="PDBsum" id="1T65"/>
<dbReference type="PDBsum" id="1XJ7"/>
<dbReference type="PDBsum" id="1XOW"/>
<dbReference type="PDBsum" id="1XQ3"/>
<dbReference type="PDBsum" id="1Z95"/>
<dbReference type="PDBsum" id="2AM9"/>
<dbReference type="PDBsum" id="2AMA"/>
<dbReference type="PDBsum" id="2AMB"/>
<dbReference type="PDBsum" id="2AO6"/>
<dbReference type="PDBsum" id="2AX6"/>
<dbReference type="PDBsum" id="2AX7"/>
<dbReference type="PDBsum" id="2AX8"/>
<dbReference type="PDBsum" id="2AX9"/>
<dbReference type="PDBsum" id="2AXA"/>
<dbReference type="PDBsum" id="2HVC"/>
<dbReference type="PDBsum" id="2OZ7"/>
<dbReference type="PDBsum" id="2PIO"/>
<dbReference type="PDBsum" id="2PIP"/>
<dbReference type="PDBsum" id="2PIQ"/>
<dbReference type="PDBsum" id="2PIR"/>
<dbReference type="PDBsum" id="2PIT"/>
<dbReference type="PDBsum" id="2PIU"/>
<dbReference type="PDBsum" id="2PIV"/>
<dbReference type="PDBsum" id="2PIW"/>
<dbReference type="PDBsum" id="2PIX"/>
<dbReference type="PDBsum" id="2PKL"/>
<dbReference type="PDBsum" id="2PNU"/>
<dbReference type="PDBsum" id="2Q7I"/>
<dbReference type="PDBsum" id="2Q7J"/>
<dbReference type="PDBsum" id="2Q7K"/>
<dbReference type="PDBsum" id="2Q7L"/>
<dbReference type="PDBsum" id="2YHD"/>
<dbReference type="PDBsum" id="2YLO"/>
<dbReference type="PDBsum" id="2YLP"/>
<dbReference type="PDBsum" id="2YLQ"/>
<dbReference type="PDBsum" id="2Z4J"/>
<dbReference type="PDBsum" id="3B5R"/>
<dbReference type="PDBsum" id="3B65"/>
<dbReference type="PDBsum" id="3B66"/>
<dbReference type="PDBsum" id="3B67"/>
<dbReference type="PDBsum" id="3B68"/>
<dbReference type="PDBsum" id="3BTR"/>
<dbReference type="PDBsum" id="3L3X"/>
<dbReference type="PDBsum" id="3L3Z"/>
<dbReference type="PDBsum" id="3RLJ"/>
<dbReference type="PDBsum" id="3RLL"/>
<dbReference type="PDBsum" id="3V49"/>
<dbReference type="PDBsum" id="3V4A"/>
<dbReference type="PDBsum" id="3ZQT"/>
<dbReference type="PDBsum" id="4HLW"/>
<dbReference type="PDBsum" id="4K7A"/>
<dbReference type="PDBsum" id="4OEA"/>
<dbReference type="PDBsum" id="4OED"/>
<dbReference type="PDBsum" id="4OEY"/>
<dbReference type="PDBsum" id="4OEZ"/>
<dbReference type="PDBsum" id="4OFR"/>
<dbReference type="PDBsum" id="4OFU"/>
<dbReference type="PDBsum" id="4OGH"/>
<dbReference type="PDBsum" id="4OH5"/>
<dbReference type="PDBsum" id="4OH6"/>
<dbReference type="PDBsum" id="4OHA"/>
<dbReference type="PDBsum" id="4OIL"/>
<dbReference type="PDBsum" id="4OIU"/>
<dbReference type="PDBsum" id="4OJ9"/>
<dbReference type="PDBsum" id="4OJB"/>
<dbReference type="PDBsum" id="4OK1"/>
<dbReference type="PDBsum" id="4OKB"/>
<dbReference type="PDBsum" id="4OKT"/>
<dbReference type="PDBsum" id="4OKW"/>
<dbReference type="PDBsum" id="4OKX"/>
<dbReference type="PDBsum" id="4OLM"/>
<dbReference type="DisProt" id="DP00492"/>
<dbReference type="ProteinModelPortal" id="P10275"/>
<dbReference type="SMR" id="P10275">
<property type="residue range" value="555-918"/>
</dbReference>
<dbReference type="BioGrid" id="106862">
<property type="interactions" value="219"/>
</dbReference>
<dbReference type="DIP" id="DIP-125N"/>
<dbReference type="IntAct" id="P10275">
<property type="interactions" value="106"/>
</dbReference>
<dbReference type="MINT" id="MINT-94801"/>
<dbReference type="STRING" id="9606.ENSP00000363822"/>
<dbReference type="BindingDB" id="P10275"/>
<dbReference type="ChEMBL" id="CHEMBL1871"/>
<dbReference type="DrugBank" id="DB01128">
<property type="generic name" value="Bicalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB04839">
<property type="generic name" value="Cyproterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01406">
<property type="generic name" value="Danazol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01395">
<property type="generic name" value="Drospirenone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00858">
<property type="generic name" value="Drostanolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08899">
<property type="generic name" value="Enzalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00687">
<property type="generic name" value="Fludrocortisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01185">
<property type="generic name" value="Fluoxymesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00499">
<property type="generic name" value="Flutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00367">
<property type="generic name" value="Levonorgestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB06710">
<property type="generic name" value="Methyltestosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08804">
<property type="generic name" value="Nandrolone decanoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00984">
<property type="generic name" value="Nandrolone phenpropionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00665">
<property type="generic name" value="Nilutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00621">
<property type="generic name" value="Oxandrolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00624">
<property type="generic name" value="Testosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01420">
<property type="generic name" value="Testosterone Propionate"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="628"/>
<dbReference type="PhosphoSite" id="P10275"/>
<dbReference type="DMDM" id="113830"/>
<dbReference type="MaxQB" id="P10275"/>
<dbReference type="PaxDb" id="P10275"/>
<dbReference type="PRIDE" id="P10275"/>
<dbReference type="Ensembl" id="ENST00000396043">
<molecule id="P10275-2"/>
<property type="protein sequence ID" value="ENSP00000379358"/>
<property type="gene ID" value="ENSG00000169083"/>
</dbReference>
<dbReference type="GeneID" id="367"/>
<dbReference type="KEGG" id="hsa:367"/>
<dbReference type="CTD" id="367"/>
<dbReference type="GeneCards" id="GC0XP066763"/>
<dbReference type="GeneReviews" id="AR"/>
<dbReference type="H-InvDB" id="HIX0056152"/>
<dbReference type="HGNC" id="HGNC:644">
<property type="gene designation" value="AR"/>
</dbReference>
<dbReference type="HPA" id="CAB000001"/>
<dbReference type="MIM" id="300068">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="312300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="313200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="313700">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P10275"/>
<dbReference type="Orphanet" id="99429">
<property type="disease" value="Complete androgen insensitivity syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="440">
<property type="disease" value="Familial hypospadias"/>
</dbReference>
<dbReference type="Orphanet" id="481">
<property type="disease" value="Kennedy disease"/>
</dbReference>
<dbReference type="Orphanet" id="90797">
<property type="disease" value="Partial androgen insensitivity syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA57"/>
<dbReference type="eggNOG" id="NOG245477"/>
<dbReference type="GeneTree" id="ENSGT00760000118887"/>
<dbReference type="HOVERGEN" id="HBG007583"/>
<dbReference type="InParanoid" id="P10275"/>
<dbReference type="KO" id="K08557"/>
<dbReference type="OrthoDB" id="EOG7J17Z7"/>
<dbReference type="PhylomeDB" id="P10275"/>
<dbReference type="TreeFam" id="TF350286"/>
<dbReference type="Reactome" id="REACT_15525">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="SignaLink" id="P10275"/>
<dbReference type="ChiTaRS" id="AR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P10275"/>
<dbReference type="GeneWiki" id="Androgen_receptor"/>
<dbReference type="GenomeRNAi" id="367"/>
<dbReference type="NextBio" id="1531"/>
<dbReference type="PMAP-CutDB" id="B1AKD7"/>
<dbReference type="PRO" id="PR:P10275"/>
<dbReference type="Bgee" id="P10275"/>
<dbReference type="CleanEx" id="HS_AR"/>
<dbReference type="ExpressionAtlas" id="P10275">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevestigator" id="P10275"/>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="IDA:MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005497">
<property type="term" value="F:androgen binding"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004882">
<property type="term" value="F:androgen receptor activity"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="IPI:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="IPI:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II core promoter proximal region sequence-specific DNA binding"/>
<property type="evidence" value="IDA:NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001077">
<property type="term" value="F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription"/>
<property type="evidence" value="IDA:NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="IPI:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:sequence-specific DNA binding transcription factor activity"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="IPI:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="IEA:InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008219">
<property type="term" value="P:cell death"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016049">
<property type="term" value="P:cell growth"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0010467">
<property type="term" value="P:gene expression"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030522">
<property type="term" value="P:intracellular receptor signaling pathway"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045720">
<property type="term" value="P:negative regulation of integrin biosynthetic process"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045726">
<property type="term" value="P:positive regulation of integrin biosynthetic process"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="IMP:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042327">
<property type="term" value="P:positive regulation of phosphorylation"/>
<property type="evidence" value="IMP:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045945">
<property type="term" value="P:positive regulation of transcription from RNA polymerase III promoter"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030850">
<property type="term" value="P:prostate gland development"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051259">
<property type="term" value="P:protein oligomerization"/>
<property type="evidence" value="IDA:MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0090003">
<property type="term" value="P:regulation of establishment of protein localization to plasma membrane"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007548">
<property type="term" value="P:sex differentiation"/>
<property type="evidence" value="NAS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006810">
<property type="term" value="P:transport"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001103">
<property type="entry name" value="Andrgn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR008946">
<property type="entry name" value="Nucl_hormone_rcpt_ligand-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF02166">
<property type="entry name" value="Androgen_recep"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00521">
<property type="entry name" value="ANDROGENR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0657">Pseudohermaphroditism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0754">Steroid-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0818">Triplet repeat expansion</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Androgen receptor" id="PRO_0000053704">
<location>
<begin position="1"/>
<end position="919"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="2">
<location>
<begin position="559"/>
<end position="631"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="2">
<location>
<begin position="559"/>
<end position="579"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="2">
<location>
<begin position="595"/>
<end position="619"/>
</location>
</feature>
<feature type="region of interest" description="Modulating">
<location>
<begin position="1"/>
<end position="558"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with LPXN">
<location>
<begin position="551"/>
<end position="919"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HIPK3" evidence="1">
<location>
<begin position="571"/>
<end position="661"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with KAT7">
<location>
<begin position="624"/>
<end position="919"/>
</location>
</feature>
<feature type="region of interest" description="Ligand-binding">
<location>
<begin position="690"/>
<end position="919"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Leu">
<location>
<begin position="54"/>
<end position="57"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="58"/>
<end position="89"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="58"/>
<end position="78"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="84"/>
<end position="89"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="193"/>
<end position="197"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="372"/>
<end position="381"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="396"/>
<end position="402"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="449"/>
<end position="472"/>
</location>
</feature>
<feature type="binding site" description="Androgen">
<location>
<position position="705"/>
</location>
</feature>
<feature type="binding site" description="Androgen">
<location>
<position position="752"/>
</location>
</feature>
<feature type="binding site" description="Androgen">
<location>
<position position="877"/>
</location>
</feature>
<feature type="site" description="Interaction with coactivator LXXL motif">
<location>
<position position="720"/>
</location>
</feature>
<feature type="site" description="Interaction with coactivator FXXLF motif">
<location>
<position position="897"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK9" evidence="80">
<location>
<position position="81"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="81">
<location>
<position position="94"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="223"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK and TNK2" evidence="58 60 78">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="346"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="357"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="362"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK and TNK2" evidence="58 60">
<location>
<position position="363"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="393"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="534"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="82">
<location>
<position position="650"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="58">
<location>
<position position="915"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="386"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="520"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="73">
<location>
<position position="845"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="73">
<location>
<position position="847"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_036889" evidence="167">
<location>
<begin position="1"/>
<end position="531"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_036890" evidence="167">
<original>GPYGDMR</original>
<variation>MILWLHS</variation>
<location>
<begin position="532"/>
<end position="538"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004679" evidence="132">
<original>E</original>
<variation>K</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_004680">
<original>L</original>
<variation>S</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_004681">
<original>L</original>
<variation>Q</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009711">
<original>Q</original>
<variation>R</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_004682">
<location>
<begin position="74"/>
<end position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009712">
<original>Q</original>
<variation>H</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009713">
<original>K</original>
<variation>R</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009224" evidence="147">
<original>Q</original>
<variation>R</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_009714" evidence="114">
<original>S</original>
<variation>R</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; 20% lower transactivation capacity." id="VAR_009715" evidence="161">
<original>G</original>
<variation>R</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009225" evidence="157">
<original>L</original>
<variation>P</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009716">
<original>M</original>
<variation>T</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009717">
<original>P</original>
<variation>S</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009718" evidence="87">
<original>P</original>
<variation>L</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009226" evidence="18">
<original>P</original>
<variation>R</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009227">
<original>P</original>
<variation>S</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; might be a polymorphism." id="VAR_009228" evidence="18">
<original>Q</original>
<variation>R</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_004683">
<location>
<begin position="465"/>
<end position="472"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009719">
<original>G</original>
<variation>S</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009720">
<original>D</original>
<variation>G</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009721">
<original>L</original>
<variation>F</variation>
<location>
<position position="547"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009722" evidence="128">
<original>P</original>
<variation>S</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009723" evidence="36">
<original>C</original>
<variation>Y</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with isolated hypospadias." id="VAR_009725" evidence="95">
<original>G</original>
<variation>V</variation>
<location>
<position position="568"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009726" evidence="97">
<original>G</original>
<variation>W</variation>
<location>
<position position="568"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009727" evidence="153">
<original>Y</original>
<variation>C</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; defective DNA binding and transactivation." id="VAR_009728" evidence="136">
<original>A</original>
<variation>D</variation>
<location>
<position position="573"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009729">
<original>L</original>
<variation>P</variation>
<location>
<position position="574"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009730" evidence="24">
<original>T</original>
<variation>A</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; lack of DNA binding." id="VAR_009731">
<original>C</original>
<variation>F</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009732" evidence="36">
<original>C</original>
<variation>R</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; reduced transcription and DNA binding." id="VAR_009733" evidence="131">
<original>C</original>
<variation>F</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009734">
<original>C</original>
<variation>Y</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009735" evidence="24">
<original>K</original>
<variation>R</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009736" evidence="115 164">
<original>V</original>
<variation>F</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009737" evidence="101">
<original>F</original>
<variation>S</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009738" evidence="131">
<original>F</original>
<variation>Y</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009739" evidence="111">
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009740">
<original>R</original>
<variation>K</variation>
<location>
<position position="585"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009741" evidence="24">
<original>A</original>
<variation>V</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009742">
<original>A</original>
<variation>S</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; abolishes dimerization." id="VAR_009743" evidence="19 93">
<original>A</original>
<variation>T</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; high dissociation rate; associated with P-617 in a PAIS patient; partially restores DNA-binding activity of P-617 mutant receptors." id="VAR_009744" evidence="36">
<original>S</original>
<variation>G</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with severe hypospadias." id="VAR_009745" evidence="5">
<original>S</original>
<variation>T</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009746" evidence="102">
<original>C</original>
<variation>F</variation>
<location>
<position position="601"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009747" evidence="101">
<original>D</original>
<variation>Y</variation>
<location>
<position position="604"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and breast cancer." id="VAR_004684" evidence="6 34 141 152">
<original>R</original>
<variation>Q</variation>
<location>
<position position="607"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and breast cancer; defective nuclear localization." id="VAR_004685" evidence="37 117 145">
<original>R</original>
<variation>K</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009748" evidence="141">
<original>N</original>
<variation>T</variation>
<location>
<position position="610"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009749">
<original>C</original>
<variation>Y</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS." id="VAR_009751" evidence="100 111 121 159">
<original>R</original>
<variation>H</variation>
<location>
<position position="615"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009752">
<original>R</original>
<variation>P</variation>
<location>
<position position="615"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009750" evidence="111">
<location>
<position position="615"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009753" evidence="127">
<original>L</original>
<variation>P</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009754" evidence="109">
<original>L</original>
<variation>R</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS; loss of DNA-binding activity; associated with G-597 in a PAIS patient." id="VAR_009755" evidence="36 75">
<original>R</original>
<variation>P</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; loss of DNA binding; somatic mutation." id="VAR_009756" evidence="20 24">
<original>C</original>
<variation>Y</variation>
<location>
<position position="619"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009757" evidence="144">
<original>R</original>
<variation>Q</variation>
<location>
<position position="629"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009758">
<original>K</original>
<variation>T</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800053." id="VAR_004686" evidence="155">
<original>A</original>
<variation>D</variation>
<location>
<position position="645"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009760">
<original>S</original>
<variation>N</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS." id="VAR_004687">
<original>I</original>
<variation>N</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009761">
<original>Q</original>
<variation>R</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009762">
<original>P</original>
<variation>H</variation>
<location>
<position position="671"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009763">
<original>I</original>
<variation>T</variation>
<location>
<position position="672"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004688" evidence="88">
<original>L</original>
<variation>P</variation>
<location>
<position position="677"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009764" evidence="6 120">
<original>E</original>
<variation>K</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_013474" evidence="27">
<original>P</original>
<variation>T</variation>
<location>
<position position="682"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009765" evidence="22 138">
<original>G</original>
<variation>A</variation>
<location>
<position position="683"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009766">
<original>V</original>
<variation>I</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009767">
<original>C</original>
<variation>R</variation>
<location>
<position position="686"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009768">
<original>A</original>
<variation>V</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009769">
<original>G</original>
<variation>E</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009770" evidence="165">
<location>
<position position="690"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004689">
<location>
<position position="692"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004690" evidence="65">
<original>D</original>
<variation>H</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; almost complete loss of androgen binding and transcription activation." id="VAR_004691" evidence="65">
<original>D</original>
<variation>N</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004692" evidence="154">
<original>D</original>
<variation>V</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009771">
<original>L</original>
<variation>M</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009772">
<original>L</original>
<variation>F</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer." id="VAR_009773" evidence="17 116 151">
<original>L</original>
<variation>H</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009774">
<original>S</original>
<variation>A</variation>
<location>
<position position="702"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009775">
<original>S</original>
<variation>C</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS." id="VAR_004693" evidence="148">
<original>S</original>
<variation>G</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009776" evidence="44 94">
<original>N</original>
<variation>S</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013475" evidence="28">
<original>N</original>
<variation>Y</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004694" evidence="125">
<original>L</original>
<variation>R</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009777" evidence="101 150">
<original>G</original>
<variation>A</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009778">
<original>G</original>
<variation>V</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009779">
<original>R</original>
<variation>T</variation>
<location>
<position position="710"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_013476" evidence="27">
<original>Q</original>
<variation>E</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009780">
<original>L</original>
<variation>F</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; gain in function." id="VAR_009781" evidence="110">
<original>V</original>
<variation>M</variation>
<location>
<position position="715"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009782">
<original>K</original>
<variation>E</variation>
<location>
<position position="717"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; found in bone metastases." id="VAR_009783">
<original>K</original>
<variation>E</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009784">
<original>A</original>
<variation>T</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009785">
<original>L</original>
<variation>F</variation>
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009786">
<original>P</original>
<variation>S</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer." id="VAR_009787">
<original>G</original>
<variation>D</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with severe hypospadias." id="VAR_009788" evidence="5 94">
<original>F</original>
<variation>L</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009789" evidence="123">
<original>R</original>
<variation>L</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009790" evidence="103">
<original>N</original>
<variation>K</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009791">
<original>L</original>
<variation>S</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; increases transcription activation." id="VAR_004695" evidence="56 90">
<original>V</original>
<variation>M</variation>
<location>
<position position="730"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004696" evidence="146">
<original>D</original>
<variation>N</variation>
<location>
<position position="732"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004697">
<original>D</original>
<variation>Y</variation>
<location>
<position position="732"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009792">
<original>Q</original>
<variation>H</variation>
<location>
<position position="733"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009793" evidence="94">
<original>I</original>
<variation>T</variation>
<location>
<position position="737"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009794" evidence="42">
<original>W</original>
<variation>R</variation>
<location>
<position position="741"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004698" evidence="133">
<original>M</original>
<variation>I</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009795" evidence="100">
<original>M</original>
<variation>V</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013477" evidence="27">
<original>G</original>
<variation>E</variation>
<location>
<position position="743"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS." id="VAR_004699" evidence="106 119 160 164">
<original>G</original>
<variation>V</variation>
<location>
<position position="743"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer." id="VAR_009796">
<original>L</original>
<variation>F</variation>
<location>
<position position="744"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009797" evidence="100">
<original>M</original>
<variation>T</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009798">
<original>V</original>
<variation>M</variation>
<location>
<position position="746"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009799">
<original>A</original>
<variation>D</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009800">
<original>A</original>
<variation>T</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009801">
<original>A</original>
<variation>V</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009802">
<original>M</original>
<variation>I</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS." id="VAR_004700" evidence="44 45 137">
<original>M</original>
<variation>V</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004701" evidence="149">
<original>G</original>
<variation>D</variation>
<location>
<position position="750"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009803">
<original>G</original>
<variation>S</variation>
<location>
<position position="750"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009804">
<original>W</original>
<variation>R</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004702" evidence="153 159">
<original>R</original>
<variation>Q</variation>
<location>
<position position="752"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and prostate cancer." id="VAR_009805" evidence="101 141">
<original>F</original>
<variation>L</variation>
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004703" evidence="108 164">
<original>F</original>
<variation>V</variation>
<location>
<position position="754"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009806">
<original>T</original>
<variation>A</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009807">
<original>N</original>
<variation>S</variation>
<location>
<position position="756"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009808" evidence="24">
<original>V</original>
<variation>A</variation>
<location>
<position position="757"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; 50% reduction in transactivation." id="VAR_009809" evidence="156">
<original>N</original>
<variation>T</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009810" evidence="44">
<original>S</original>
<variation>F</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009811">
<original>S</original>
<variation>P</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004704" evidence="149">
<original>L</original>
<variation>F</variation>
<location>
<position position="762"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and prostate cancer; partial loss of androgen binding." id="VAR_004705" evidence="76 89">
<original>Y</original>
<variation>C</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009812" evidence="94">
<original>Y</original>
<variation>H</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009813" evidence="100">
<original>F</original>
<variation>L</variation>
<location>
<position position="764"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004707" evidence="38 146 149 163">
<original>A</original>
<variation>T</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009814">
<original>A</original>
<variation>V</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009815">
<original>P</original>
<variation>S</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009816" evidence="164">
<original>D</original>
<variation>E</variation>
<location>
<position position="767"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009817">
<original>L</original>
<variation>P</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009818" evidence="101">
<original>N</original>
<variation>H</variation>
<location>
<position position="771"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009819" evidence="3">
<original>E</original>
<variation>A</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009820" evidence="145">
<original>E</original>
<variation>G</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding; frequent mutation." id="VAR_004709" evidence="54 72 79 137 153">
<original>R</original>
<variation>C</variation>
<location>
<position position="774"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS; almost complete loss of androgen binding." id="VAR_004708" evidence="44 54 94">
<original>R</original>
<variation>H</variation>
<location>
<position position="774"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004710" evidence="89 101 140">
<original>R</original>
<variation>W</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS." id="VAR_004711" evidence="130 133 137">
<original>M</original>
<variation>I</variation>
<location>
<position position="780"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009821">
<original>S</original>
<variation>N</variation>
<location>
<position position="782"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding and of transactivation." id="VAR_004712" evidence="163">
<original>C</original>
<variation>Y</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004713" evidence="50">
<original>M</original>
<variation>V</variation>
<location>
<position position="787"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009822">
<original>R</original>
<variation>S</variation>
<location>
<position position="788"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009823" evidence="99">
<original>L</original>
<variation>F</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009824">
<original>S</original>
<variation>P</variation>
<location>
<position position="791"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_009825" evidence="114">
<original>E</original>
<variation>D</variation>
<location>
<position position="793"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004714" evidence="137">
<original>F</original>
<variation>S</variation>
<location>
<position position="794"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS, AIS and prostate cancer; reduced transcription activation." id="VAR_004715" evidence="87 94 126 133 162">
<original>Q</original>
<variation>E</variation>
<location>
<position position="798"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009826">
<original>C</original>
<variation>Y</variation>
<location>
<position position="806"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of transactivation." id="VAR_004716" evidence="118">
<original>M</original>
<variation>R</variation>
<location>
<position position="807"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009827" evidence="16">
<original>M</original>
<variation>T</variation>
<location>
<position position="807"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; 25% androgen binding." id="VAR_004717" evidence="89">
<original>M</original>
<variation>V</variation>
<location>
<position position="807"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009828" evidence="13">
<original>L</original>
<variation>F</variation>
<location>
<position position="812"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS." id="VAR_004718">
<original>S</original>
<variation>N</variation>
<location>
<position position="814"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009829" evidence="157">
<original>G</original>
<variation>A</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009830">
<original>L</original>
<variation>V</variation>
<location>
<position position="821"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_013478" evidence="27">
<original>F</original>
<variation>V</variation>
<location>
<position position="827"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009831">
<original>L</original>
<variation>P</variation>
<location>
<position position="830"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004719" evidence="91">
<original>R</original>
<variation>L</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004720" evidence="13 79 91">
<original>R</original>
<variation>Q</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_009832" evidence="42">
<original>Y</original>
<variation>C</variation>
<location>
<position position="834"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004721" evidence="105 133 160">
<original>R</original>
<variation>C</variation>
<location>
<position position="840"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004722" evidence="163">
<original>R</original>
<variation>G</variation>
<location>
<position position="840"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004723" evidence="96 105 109 113 120 135 141">
<original>R</original>
<variation>H</variation>
<location>
<position position="840"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009229" evidence="15">
<original>R</original>
<variation>S</variation>
<location>
<position position="840"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009833">
<original>I</original>
<variation>S</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004724" evidence="120 141">
<original>I</original>
<variation>T</variation>
<location>
<position position="842"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009834" evidence="24">
<original>R</original>
<variation>G</variation>
<location>
<position position="846"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009835">
<original>R</original>
<variation>K</variation>
<location>
<position position="854"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004725" evidence="44 89 139 147 164">
<original>R</original>
<variation>C</variation>
<location>
<position position="855"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; strongly reduced transcription activation." id="VAR_004726" evidence="107 133 141 142">
<original>R</original>
<variation>H</variation>
<location>
<position position="855"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009836">
<original>F</original>
<variation>L</variation>
<location>
<position position="856"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009837">
<original>L</original>
<variation>R</variation>
<location>
<position position="863"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009838" evidence="44">
<original>D</original>
<variation>G</variation>
<location>
<position position="864"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004727" evidence="149">
<original>D</original>
<variation>N</variation>
<location>
<position position="864"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009839">
<original>S</original>
<variation>P</variation>
<location>
<position position="865"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004728">
<original>V</original>
<variation>E</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004729" evidence="37 120 122">
<original>V</original>
<variation>L</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer." id="VAR_004730" evidence="79 86 122 141">
<original>V</original>
<variation>M</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004731" evidence="107 133">
<original>I</original>
<variation>M</variation>
<location>
<position position="869"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009840" evidence="150">
<original>A</original>
<variation>G</variation>
<location>
<position position="870"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009841" evidence="104">
<original>A</original>
<variation>V</variation>
<location>
<position position="870"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009842" evidence="3">
<original>R</original>
<variation>G</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013479" evidence="27">
<original>H</original>
<variation>R</variation>
<location>
<position position="874"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; increases affinity for testosterone, androgen sensitivity and transcription activation." id="VAR_009843">
<original>H</original>
<variation>Y</variation>
<location>
<position position="874"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; alters receptor specificity so that transcription is activated by antiandrogens, such as cyproterone acetate; found in bone metastases." id="VAR_004732" evidence="9 17 48 85 112 116 134">
<original>T</original>
<variation>A</variation>
<location>
<position position="877"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009844">
<original>T</original>
<variation>S</variation>
<location>
<position position="877"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013480" evidence="27">
<original>D</original>
<variation>Y</variation>
<location>
<position position="879"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009845">
<original>L</original>
<variation>Q</variation>
<location>
<position position="880"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009846" evidence="92">
<original>L</original>
<variation>V</variation>
<location>
<position position="881"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009847">
<original>M</original>
<variation>V</variation>
<location>
<position position="886"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS." id="VAR_009848" evidence="109 143">
<original>V</original>
<variation>M</variation>
<location>
<position position="889"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009849" evidence="9">
<original>D</original>
<variation>N</variation>
<location>
<position position="890"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009850">
<original>F</original>
<variation>L</variation>
<location>
<position position="891"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004733" evidence="7 12 166">
<original>P</original>
<variation>L</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; low androgen binding and transactivation." id="VAR_004734" evidence="163">
<original>M</original>
<variation>T</variation>
<location>
<position position="895"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009851">
<original>A</original>
<variation>T</variation>
<location>
<position position="896"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009852">
<original>I</original>
<variation>T</variation>
<location>
<position position="898"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009853">
<original>Q</original>
<variation>R</variation>
<location>
<position position="902"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009854">
<original>V</original>
<variation>M</variation>
<location>
<position position="903"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009855">
<original>P</original>
<variation>H</variation>
<location>
<position position="904"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009856">
<original>P</original>
<variation>S</variation>
<location>
<position position="904"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; almost complete loss of transcription activation." id="VAR_004735" evidence="149">
<original>L</original>
<variation>F</variation>
<location>
<position position="907"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009857">
<original>G</original>
<variation>E</variation>
<location>
<position position="909"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009858" evidence="124">
<original>G</original>
<variation>R</variation>
<location>
<position position="909"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009859" evidence="151">
<original>K</original>
<variation>R</variation>
<location>
<position position="910"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009860" evidence="14">
<original>V</original>
<variation>L</variation>
<location>
<position position="911"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004736">
<original>P</original>
<variation>S</variation>
<location>
<position position="913"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009861" evidence="148">
<original>F</original>
<variation>L</variation>
<location>
<position position="916"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009862">
<original>H</original>
<variation>R</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009863">
<original>Q</original>
<variation>R</variation>
<location>
<position position="919"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced cell growth." evidence="80">
<original>S</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation and phosphorylation by TNK2. Complete loss of TNK2-dependent phosphorylation; when associated with F-363." evidence="58 60">
<original>Y</original>
<variation>F</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation and phosphorylation by TNK2. Complete loss of TNK2-dependent phosphorylation; when associated with F-267." evidence="58 60">
<original>Y</original>
<variation>F</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatest decrease of CSK-induced phosphorylation and inhibition of transcriptional activity induced by EGF." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="534"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="mutagenesis site" description="Alters receptor specificity, so that transcription is activated by the antiandrogen cyproterone acetate." evidence="59">
<original>L</original>
<variation>A</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transcription activation in the presence of androgen and of interaction with NCOA2." evidence="47 63">
<original>K</original>
<variation>A</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased transcription activation in the presence of androgen." evidence="55">
<original>W</original>
<variation>L</variation>
<location>
<position position="741"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents ubiquitination by RNF6. Prevents AR transcriptional activation by RNF14 in absence of hormone." evidence="73">
<original>K</original>
<variation>R</variation>
<location>
<position position="845"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially prevents ubiquitination by RNF6." evidence="73">
<original>K</original>
<variation>R</variation>
<location>
<position position="847"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transcription activation in the presence of androgen." evidence="47 63">
<original>E</original>
<variation>A</variation>
<variation>Q</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transcription activation in the presence of androgen." evidence="47 63">
<original>E</original>
<variation>K</variation>
<variation>R</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in CSK-induced phosphorylation." evidence="58">
<original>Y</original>
<variation>F</variation>
<location>
<position position="915"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA51780." ref="5" evidence="167">
<original>G</original>
<variation>A</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3 and 6; AAA51771/AAA51772." ref="3 6" evidence="167">
<original>A</original>
<variation>R</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA51775 and 12; AAA51770." ref="2 12" evidence="167">
<original>G</original>
<variation>E</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 14; AAA51774." ref="14" evidence="167">
<original>E</original>
<variation>K</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 18; AAB21256/AAB21257." ref="18" evidence="167">
<original>L</original>
<variation>P</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 18; AAB21256/AAB21257." ref="18" evidence="167">
<original>N</original>
<variation>I</variation>
<location>
<position position="675"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA51780." ref="5" evidence="167">
<original>L</original>
<variation>M</variation>
<location>
<position position="810"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="22"/>
<end position="29"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="666"/>
<end position="668"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="672"/>
<end position="680"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="691"/>
<end position="693"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="697"/>
<end position="720"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="725"/>
<end position="727"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="730"/>
<end position="757"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="760"/>
<end position="765"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="768"/>
<end position="770"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="772"/>
<end position="777"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="781"/>
<end position="796"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="801"/>
<end position="812"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="814"/>
<end position="817"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="824"/>
<end position="842"/>
</location>
</feature>
<feature type="turn">
<location>
<begin position="843"/>
<end position="845"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="850"/>
<end position="883"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="884"/>
<end position="886"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="893"/>
<end position="901"/>
</location>
</feature>
<feature type="helix">
<location>
<begin position="903"/>
<end position="907"/>
</location>
</feature>
<feature type="strand">
<location>
<begin position="910"/>
<end position="913"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10022458"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10075738"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10092153"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10221692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10221770"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10332029"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10363963"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10383460"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10400640"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10404311"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10458483"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10470409"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10502786"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10543676"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10569618"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10571951"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10590024"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10598582"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10625666"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10629558"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10690872"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10706109"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10930412"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11121022"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11587068"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11744994"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12039962"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12361945"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12415108"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612053"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12958311"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1303262"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1307250"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1316540"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1424203"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1426313"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1430233"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14573606"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14609956"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1464650"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14664718"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1480178"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1487249"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15525515"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15563469"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1562539"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15634333"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1569163"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15851746"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16027218"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16051670"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1609793"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16129672"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1631125"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951154"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17045208"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17311914"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17494760"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17550981"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17587566"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17591767"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17711855"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1775137"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17911242"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18007036"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18084323"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18222118"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18451096"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18451177"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1856263"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19345326"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19909775"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1999491"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2010552"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20501646"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20623637"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2082179"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20980437"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21512132"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22031296"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22170608"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2260966"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2594783"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7511268"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7537149"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7581399"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7591265"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7633398"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7641413"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7649358"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7671849"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7673412"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7909256"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7910529"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7929841"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7962294"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7970939"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7981687"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7981689"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7993455"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8033918"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8040309"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8096390"/>
</source>
</evidence>
<evidence key="107" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8097257"/>
</source>
</evidence>
<evidence key="108" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8103398"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8126121"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8145761"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8162033"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8187068"/>
</source>
</evidence>
<evidence key="113" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8205256"/>
</source>
</evidence>
<evidence key="114" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8213813"/>
</source>
</evidence>
<evidence key="115" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8224266"/>
</source>
</evidence>
<evidence key="116" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8274409"/>
</source>
</evidence>
<evidence key="117" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8281139"/>
</source>
</evidence>
<evidence key="118" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8281140"/>
</source>
</evidence>
<evidence key="119" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8325932"/>
</source>
</evidence>
<evidence key="120" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8325950"/>
</source>
</evidence>
<evidence key="121" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8413310"/>
</source>
</evidence>
<evidence key="122" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8446106"/>
</source>
</evidence>
<evidence key="123" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8530589"/>
</source>
</evidence>
<evidence key="124" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8550758"/>
</source>
</evidence>
<evidence key="125" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626869"/>
</source>
</evidence>
<evidence key="126" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8628719"/>
</source>
</evidence>
<evidence key="127" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8647313"/>
</source>
</evidence>
<evidence key="128" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8683794"/>
</source>
</evidence>
<evidence key="129" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723113"/>
</source>
</evidence>
<evidence key="130" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8768864"/>
</source>
</evidence>
<evidence key="131" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8809734"/>
</source>
</evidence>
<evidence key="132" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8823308"/>
</source>
</evidence>
<evidence key="133" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8824883"/>
</source>
</evidence>
<evidence key="134" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8827083"/>
</source>
</evidence>
<evidence key="135" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8830623"/>
</source>
</evidence>
<evidence key="136" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8918984"/>
</source>
</evidence>
<evidence key="137" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8990010"/>
</source>
</evidence>
<evidence key="138" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9000575"/>
</source>
</evidence>
<evidence key="139" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9001799"/>
</source>
</evidence>
<evidence key="140" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9007482"/>
</source>
</evidence>
<evidence key="141" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9039340"/>
</source>
</evidence>
<evidence key="142" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9106550"/>
</source>
</evidence>
<evidence key="143" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9160185"/>
</source>
</evidence>
<evidence key="144" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9184448"/>
</source>
</evidence>
<evidence key="145" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9196614"/>
</source>
</evidence>
<evidence key="146" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9252933"/>
</source>
</evidence>
<evidence key="147" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9255042"/>
</source>
</evidence>
<evidence key="148" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9302173"/>
</source>
</evidence>
<evidence key="149" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9328206"/>
</source>
</evidence>
<evidence key="150" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9329414"/>
</source>
</evidence>
<evidence key="151" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9438000"/>
</source>
</evidence>
<evidence key="152" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9543136"/>
</source>
</evidence>
<evidence key="153" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9544375"/>
</source>
</evidence>
<evidence key="154" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554754"/>
</source>
</evidence>
<evidence key="155" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554755"/>
</source>
</evidence>
<evidence key="156" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9607727"/>
</source>
</evidence>
<evidence key="157" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9610419"/>
</source>
</evidence>
<evidence key="158" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9627582"/>
</source>
</evidence>
<evidence key="159" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9698822"/>
</source>
</evidence>
<evidence key="160" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9768671"/>
</source>
</evidence>
<evidence key="161" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9788719"/>
</source>
</evidence>
<evidence key="162" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9851768"/>
</source>
</evidence>
<evidence key="163" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9856504"/>
</source>
</evidence>
<evidence key="164" type="ECO:0000269">
<source ref="107"/>
</evidence>
<evidence key="165" type="ECO:0000269">
<source ref="115"/>
</evidence>
<evidence key="166" type="ECO:0000269">
<source ref="173"/>
</evidence>
<evidence key="167" type="ECO:0000305"/>
<sequence length="919" mass="98989" checksum="93B096927740B6FF" modified="1990-04-01" version="2">
MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQ
QQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSA
LECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLK
DILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKA
VSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKS
TEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSR
DYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGP
GSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPY
GYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLE
TARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRND
CTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLT
VSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAK
ALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRM
YSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDR
IIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIIS
VQVPKILSGKVKPIYFHTQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>